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Abstract 
 
The purpose of oral toxicity study A in the EU project G-TwYST was to assess the chronic and 
carcinogenic effects of genetically modified (GM) maize NK 603, grown both with and without the 
use of RoundUp, when fed to rats for a period of two years at incorporation rates of 11% and 33% in 
the feed. The effects were assessed relative to the responses for rats fed the near-isogenic non-GM 
maize, and the differences were compared.  
The results of G-TwYST study A, except for the histopathological results which are reported 
separately, are given in five reports: four specific reports about the statistical analysis for data 
measured after 3, 6, 12 and 24 months, and a main report summarising all study results (Goedhart & 
van der Voet 2018). This report is about the results after 12 months.  
The differences between feeding groups were compared, using a recently developed method for 
equivalence testing, to differences between non-GM feeds obtained in previous studies performed in 
the EU project GRACE. No historical data for 12 months old rats were available. Therefore it was only 
possible to perform equivalence tests using the 3 months data from the GRACE study as reference 
data. However, variation within the dose groups was much larger after 12 months than after 3 
months for many endpoints, which obstructed the use of equivalence tests with historical references. 
It is concluded that reference data for 12 months would need to be collected for this type of 
equivalence testing in chronic animal studies. 
This report also contains results for equivalence testing using external target effect sizes for a limited 
set of variables, results for classical statistical analysis of differences, graphs of standardised effect 
sizes such as performed in the GRACE study and results of a factorial analysis.   
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1 Introduction 
 
The purpose of oral toxicity study A in the EU project G-TwYST was to assess the effects of genetically 
modified (GM) maize NK 603, grown both with and without the use of RoundUp, when fed to rats for 
a period of one year (chronic toxicity study) and two years (carcinogenicity study), at incorporation 
rates of 11% and 33% in the feed. The effects of the GM maize were assessed relative to the 
responses for rats fed the near-isogenic non-GM maize. The chronic toxicity and carcinogenicity 
study ran in parallel. At 12 months part of the rats were euthanized and their organs were obtained, 
weighted and examined by the G-TwYST histopathological expert. The remaining rats were kept until 
24 months, or until premature death, and were then assessed in the same way.  
Rat weights and feed intake were measured weekly or bi-weekly. Haematology, clinical biochemistry 
in blood and urine, differential white blood cell counts, and urine volume and colour were obtained 
for a subset of animals after 3, 6, 12 and 24 months. This report describes in detail the results of the 
statistical analyses for the following data obtained after 12 months: 
• Body weight at 6 months, growth rate months 6-12, mean feed intake (35 cages/group); 
• Haematology (20 cages/group); 
• Clinical biochemistry in blood (20 cages/group); 
• Clinical biochemistry in urine (15 cages/group); 
• Urine volume and colour (15 cages/group); 
• Organ weights as percentage of body weight (10 cages/group). 
This report is organised as follows. Section 2 describes the data obtained after 12 months, initial data 
pre-processing, graphical summaries of growth and feed intake over time, outlier identification and 
checking of assumptions which are made in the statistical analysis. Section 3 presents detailed results 
of the statistical analyses. More details are provided in several appendices to this report. For a 
description of the statistical methods, and for a summary and discussion of results for all months, the 
reader is referred to the main study A report (Goedhart & van der Voet 2018). 
2 Data 
2.1 Data obtained after 12 months in G-TwYST study A 
The available files for the data obtained after 12 months in G-TwYST study A are given in Table 1. 
Note that the animal weights and intakes for months 7-9 and for months 10-12 were given in 
separate files. There were also “Tab_10” and “Tab_12” files with relative organ weights;  and it was 
checked that these indeed contain absolute organ weights divided by the last observed weight. 
GenStat programs “12-Males.gen” and “12-Females.gen” were used to combine all the data into 
single Excel files, separately for males and females. All animals survived the first 12 months, except 
for 7 male and 9 female rats (Table 2). It is assumed that these premature deaths are not connected 
to the experiment.  
Some CHOL and cHGB were given as bounds; the number of such values are given in Table 3. The 
original Excel files with the haematology data (Tab_5 and Tab_6) contain remarks given in Table 4. 
Values with such remarks were set to missing, see for Table 6 for details. For most Urine variables 
G-TwYST Study A  Statistical report month 12 
4 
 
only a limited number of values have been observed, see Table 5. It is evident that a statistical 
analysis of uColour, uBil, uNit, uProtein, uGlu, uHemogl and uUrobili is not very useful. Therefore, 
only the Urine variables uVol, uVolW, uLeu, uOsmoll, uKeton and upH were statistically analysed. 
Table 1 Data files for G-TwYST study A after 9/12 months. 
Data files after 9 months Date Time Size (b) 
Tab_1_G_TwYST_2yr st_A_9_mon_Body weight_Mal.xlsx 09-01-2017 15:44 185,641 
Tab_2_G_TwYST_2yr st_A_9_mon_Body weight_Fem.xlsx 09-01-2017 15:45 184,803 
Correct data_rev_1_Feed consumption_12_mon_G_TwYST_A_Females.xlsx 20-10-2017 07:08 164,942 
Correkt data_rev_1_Feed consumption_12_mon_G_TwYST_A_Males.xlsx 20-09-2017 12:00 168,346 
Data files after 12 months Date Time Size (b) 
Tab_1_G_TwYST_2yr st_A_12_mon_Body weight_Mal.xlsx 20-01-2017 09:59 122,835 
Tab_2_G_TwYST_2yr st_A_12_mon_Body weight_Fem.xlsx 10-01-2017 10:26 127,372 
Correct data_rev_1_Feed consumption_12_mon_G_TwYST_A_Females.xlsx 20-10-2017 07:08 164,942 
Correkt data_rev_1_Feed consumption_12_mon_G_TwYST_A_Males.xlsx 20-09-2017 12:00 168,346 
Tab_5_G_TwYST_2yr st_12 mon_Haemat_Mal.xlsx 04-01-2017 14:08 83,193 
Tab_6_G_TwYST_2yr st_12 mon_Haemat_Fem.xlsx 04-01-2017 15:14 86,254 
Tab_7a_G_TwYST_2yr st_A_12 mon_Clin_Chem_bl_Mal.xlsx 04-01-2017 14:07 101,064 
Tab_7b_G_TwYST_2yr st_A_12 mon_Clin_Chem_ur_Mal.xlsx 04-01-2017 14:06 87,697 
Tab_8a_G_TwYST_2yr st_A_12 mon_Clin_Chem_bl_Fem.xlsx 04-01-2017 15:34 102,362 
Tab_8b_G_TwYST_2yr st_A_12 mon_Clin_Chem_ur_Fem.xlsx 04-01-2017 15:38 88,887 
Bl_ur_12 mon_G_TwYST_2yr st_A_Fem_time course.xlsx 11-01-2017 15:18 116,198 
Bl_ur_12 mon_G_TwYST_2yr st_A_Mal_time course.xlsx 11-01-2017 15:21 113,188 
Tab_9_G_TwYST_2yr st_A_Abs_organ weights_Mal.xlsx 10-01-2017 10:52 48,673 
Tab_11_G_TwYST_2yr st_A_Abs_weight organs_Fem.xlsx 10-01-2017 10:50 40,189 
 
Table 2 Animals that died before the end of month 12. 
Sex Rat Cage Feed Day of Death 
Female 610 555 NK11- 86 
Female 785 643 Control 98 
Male 199 100 NK11+ 182 
Female 667 584 NK11+ 202 
Male 148 74 NK11+ 231 
Female 632 566 NK11- 238 
Male 101 51 NK11- 245 
Female 848 674 Control 245 
Female 745 623 NK33- 299 
Female 613 557 NK11- 323 
Female 804 652 Control 332 
Male 2 1 NK33+ 347 
Male 85 43 NK11- 351 
Male 33 17 NK33+ 352 
Male 228 114 NK33- 363 
Female 770 635 NK33- 363 
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Table 3 Number of animals for which bounded values were provided.  
Variable Males Females 
Con NK11- NK33- NK11+ NK33+ Con NK11- NK33- NK11+ NK33+ 
CHOL  < 1.16 - - - - - - - - - - 
cHGB  < 27.5 - 1 2 2 - 6 11 7 4 9 
cHGB  > 522.5 - - - - - - - - - - 
ALP < 0.17 - - - - - 1 - - - 1 
 
Table 4 Remarks by SZU in original Excel data files; the accompanying values have been set to 
missing. 
Variable Remark 
WBC High count WBC 
WBC High count of WBC and PLT, no calculated lymphocytes 
WBC Low WBC and platelet count, probably due to microclots 
HGB No calculated HGB (low blood) 
PLT Low platelet count, probably due to microclots 
PLT High count PLT 
PLT High count of WBC and PLT, no calculated lymphocytes 
PLT Low WBC and platelet count, probably due to microclots 
 
Table 5 Urine variables with only a limited set of observed values which are given in the heading 
of each sub-tables The table entries give the number of times each value occurs for male 
and female rats. Only uLeu and uKeton were statistically analysed. 
uColour Missing 1 2 3   
Male 204 - 145 1   
Female 199 2 147 2   
uBil Missing 0     
Male 203 147     
Female 199 151     
uLeu Missing 0 25 100 500  
Male 203 5 28 66 48  
Female 199 43 51 42 15  
uNit Missing 0     
Male 203 147     
Female 199 151     
uProtein Missing 0.00 0.25 0.75 1.50 5.00 
Male 203 99 22 6 14 6 
Female 199 128 14 8 1 - 
uGlu Missing 1     
203 203 147 5 8 28 203 
199 199 151 3 2 7 199 
uHemogl Missing 0 10 25 50 250 
Male 203 98 8 5 8 28 
Female 199 132 7 3 2 7 
uKeton Missing 0.0 0.5 1.5   
Male 203 66 37 44   
Female 199 110 32 9   
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uUrobili Missing 1     
Male 203 147     
Female 199 151     
 
2.2 Growth curves and feed intake 
For each individual rat a simple linear regression, 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡 = 𝛼𝛼 + 𝛽𝛽 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊, was fitted to the observed 
weights between weeks 27 and 52, and the growthRate was defined as 𝛾𝛾 = log(𝛽𝛽). In Appendix 1 
the observed weights are graphically displayed along with the fitted line and, in the bottom right 
corner, the resulting estimate of the growth rate 𝛾𝛾. Initially, absolute standardized residuals, 
resulting from the fitted curve, which were larger than 3, were marked and these were checked for 
errors by SZU. This led to some corrections. The corrections are listed in Table 6. The linear 
regression line generally fits very well, especially for male rats. Only for male rats 74, 301 and 341 
one or more observed weights differ more than 5% from the fitted values, as is depicted by the larger 
plotting symbols in Appendix 1. However, such discrepancies were observed for 88 female rats. For 
female rats 841 and 843 the estimate of 𝛽𝛽 was negative; this estimate was replaced by 0.217 which is 
half the minimum of all other estimates. For these two female rats these values are marked as 
outliers. The final weight Weight_52 and the growthRate parameter 𝛾𝛾 were statistically analysed. 
The mean weight for each feeding group is given in Figure 1, while the mean weight gain per day per 
animal in each week is given in Figure 2. Feed consumption for each cage in units g/animal/day is 
depicted in Appendix 2. The mean feed consumption for each feeding group is given in Figure 3.  
 
 
Figure 1 Mean body weights versus week for each feeding group for male rats (left) and for 
female rats (right). 
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Figure 2 Mean body weights gain (g/day/animal) versus week for each feeding group for male 
rats (left) and for female rats (right). 
 
 
Figure 3 Mean feed consumption (g/day/animal) versus week for each feeding group for male 
rats (left) and for female rats (right). 
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2.3 Outliers and checking of ANOVA assumptions 
These analyses and changes to the data were made before the feeding group codes were unblinded. 
The cage means, after a log transformation, for each observed variable were statistically analysed by 
means of an analysis of variance using the model “Block + Group” according to the randomized block 
design. Grubbs’ outlier test at the 1% level was sequentially applied to the residuals to detect 
outliers. This resulted in a number of outliers which were first presented to the study director and 
then to the G-TwYST coordinator. Outliers were classified as either (1) typos or physiologically 
improbable values or (2) values that might be realistic. For the first category the values were set to 
missing, effectively removing the outlier completely. For the second category a statistical analysis 
without and with these outlier was performed. The analyses presented in this report are without the 
outliers. Analyses including outliers are presented in Appendix 11. Table 6 lists all the initially 
modified values and outliers. Residual plots which include the outliers (i.e. including the yellow 
values in Table 6) are given in Figure 4. From this it is clear that these are indeed outliers; note that 
the outliers for growthRate in females are due to negative regression coefficients in the linear 
regression of weights. 
 
Table 6 Values that have been modified, deleted, or were considered as possible outliers, before 
unblinding of the feeding groups. Values which are not coloured were modified or 
deleted following comments of SZU. The red and yellow values were presented to the 
G-TwYST coordinator. He decided which values should be deleted (red) and which values 
should be considered as possible outliers (yellow). Comments by the authors of this 
report are given in black, while comments of the G-TwYST coordinator are given in red. 
Sex Variable Animal Cage oldValue newValue Comment 
Males WBC 35 18 2.9 delete Comment in datafile: microclots 
Males WBC 59 30 14.6 delete Comment in datafile: highCount 
Males WBC 81 41 15.6 delete Comment in datafile: highCount 
Males WBC 89 45 14.6 delete Comment in datafile: highCount 
Males PLT 35 18 177 delete Comment in datafile: microclots 
Males PLT 59 30 1576 delete Comment in datafile: highCount 
Males PLT 89 45 1524 delete Comment in datafile: highCount 
Males Weight_35 101 51 415.23 delete Rat died between week 35 and 37 
Males Feed_35 101 51 13.64 delete Rat died between week 35 and 37 
Males Weight_33 148 74 383.61 delete Rat died between week 33 and 35 
Males Feed_33 148 74 11.07 delete Rat died between week 33 and 35 
Males Weight_45 2 1 602.09 delete Rat died between week 49 and 51 
Males Weight_47 2 1 534.66 delete Rat died between week 49 and 51 
Males Weight_49 2 1 493.23 delete Rat died between week 49 and 51 
Males Feed_45 2 1 19.49 delete Rat died between week 49 and 51 
Males Feed_47 2 1 15.08 delete Rat died between week 49 and 51 
Males Feed_49 2 1 16.56 delete Rat died between week 49 and 51 
Males Feed_51 33 17 22.18 delete Rat died between week 49 and 51 
Males Weight_51 228 114 537.05 delete Rat died between week 51 and 54 
Males Feed_51 228 114 15.21 delete Rat died between week 51 and 52 
Males Feed_52 228 114 22.77 delete Rat died between week 51 and 52 
Males Weight_29 222 111 598.55 559.55 Mistake in copying from primary 
 Males growthRate 86 43 1.823 outlier Grubbs’ test significant (p=0.001) 
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Males RBC 35 18 5.06 outlier 
Same animal 35; smallest value; the 
value is still realistic 
Males HGB 35 18 11.2 outlier Same animal 35; smallest value; the value is still realistic 
Males HCT 35 18 32.2 outlier 
Same animal 35; smallest value; the 
value is still realistic 
Males Crea 156 78 74.9 outlier Largest value; if Urea is also high, could indicate renal insufficiency 
Males Testis_R 160 80 0.5066 outlier 
Extremely small value; the value is 
still realistic 
Males Testis_L 160 80 0.4908 outlier Extremely small value; the value is still realistic 
Males Testis 160 80 0.4987 outlier 
Extremely small value; the value is 
still realistic 
Males Kidney_L 224 112 3.1137 1.55685 Weight of BOTH kidneys; corrected such that the sum equals 3.1137 
Sex Variable Animal Cage oldValue newValue Comment 
Females WBC 506 503 * delete Comment in datafile: noBlood 
Females WBC 680 590 41.7 delete Comment in datafile: highCount 
Females WBC 726 613 * delete Comment in datafile: clottedBlood 
Females WBC 846 673 1.6 delete Comment in datafile: microclots 
Females WBC 799 650 24.1 delete Comment in datafile: highCount 
Females HGB 654 577 1 delete Comment in datafile: lowBlood 
Females PLT 680 590 1959 delete Comment in datafile: highCount 
Females PLT 799 650 1872 delete Comment in datafile: highCount 
Females PLT 846 673 61 delete Comment in datafile: microclots 
Females Weight_33 632 566 260.8 delete Rat died between week 33 and 35 
Females Feed_35 632 566 17.51 delete Rat died between week 33 and 35 
Females Feed_29 667 584 24.76 delete Rat died between week 27 and 29 
Females Feed_35 847 674 25.79 delete Rat died between week 33 and 35 
Females Feed_45 613 557 11.48 delete Rat died between week 45 and 47 
Females Feed_52 770 635 26.49 delete Rat died between week 45 and 48 
Females Weight_47 804 652 264.77 delete Rat died between week 47 and 49 
Females Feed_47 803 652 11.79 delete Rat died between week 47 and 49 
Females Feed_49 803 652 25.11 delete Rat died between week 47 and 49 
Females Weight_39 786 643 248.57 298.57 Mistake in copying from primary 
 Females growthRate 841 671 -1.528 outlier Estimate 𝛽𝛽 is negative 
Females growthRate 843 672 -1.528 outlier Estimate 𝛽𝛽 is negative 
Females MCV 718 609 67.7 outlier Animal 718 has consistent large values in all three months; outlier 
Females RBC 588 544 4.75 delete 
Same animal 588;  smallest value in 
this month; very low value 
Females HGB 588 544 5.9 delete Same animal 588;  two smallest values in this month are considered 
      
   Females HCT 588 544 26.6 delete 
Same animal 588;  smallest value in 
this month; un-physiologically low 
 
Females MCH 588 544 12.4 delete 
Same animal 588; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); because extremely low HGB 
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Females MCHC 588 544 22.2 delete 
Same animal 588; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); because extremely low HGB 
Females MCH 654 577 1.3 delete 
Same animal 654; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); un-physiologically low value 
Females MCHC 654 577 2.3 delete 
Same animal 654; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); un-physiologically low value 
Females HGB 762 631 8.4 delete 
Same animal 762;  two smallest 
values in this month are considered 
outliers (see animals 588 & 762); 
extremely low HGB 
Females MCH 762 631 11 delete 
Same animal 762; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); because of very low HGB 
Females MCHC 762 631 18.7 delete 
Same animal 762; three smallest 
values in this month are considered 
outliers (see animals 588, 654 & 
762); because of extremely low HGB 
Females LYMR 585 543 41.1 outlier 
Only a single value in this cage; 
There is a smaller value; outlier 
 Females LYMA 846 673 1.2 outlier Smallest value in this month; outlier 
 
Without these outliers cage means on the original scale are given in Appendix 3, while cage means 
after a log transformation of the individual data are given in Appendix 4. Normal probability plots of 
the ANOVA residuals, of an analysis on cage means after log transformation, are given in Appendix 5. 
To aid interpretation a 99% envelope is added to the probability plots, such that only values outside 
the envelop might be suspicious. Appendix 6 gives plots of residuals versus fitted values after the 
same analysis of variance. These residual plots are generally satisfactory implying that the ANOVA 
assumptions, homogeneity of variance and, less importantly, normality, are generally fulfilled. 
 
2.4 Summary tables  
Summary tables, on the original non-transformed scale, of number of observations, means, standard 
deviations and coefficients of variation (%), classified by the feeding groups, are given in Table 7 for 
males and in Table 8 for females. These tables were obtained by first calculating cage means and 
then calculating the summary statistics. The number of cages per feeding group is 35 for weights, 20 
for haematology, differential WBC and clinical biochemistry, and 10 for Urine data. 
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Figure 4 Residuals along the y-axis versus fitted values 
along the x-axis resulting from an analysis of variance on 
cage means after log transforming the data. Solid 
symbols denote outliers found by sequentially applying 
Grubbs’ outlier test at the 1% level to the residuals. 
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Table 7 Summary statistics for male rats classified by the feeding groups: number of cages (N), means (Mean), standard deviations (Sd) and 
coefficients of variation (CV). The summary statistics are obtained from cage means. 
Weights Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Weight_52 35 599 41.6 6.9 35 586 60.3 10.3 35 598 56.2 9.4 35 597 54.2 9.1 35 614 60.0 9.8 
growthRate 35 1.37 0.21 15.5 34 1.32 0.27 20.1 35 1.39 0.23 16.6 35 1.38 0.24 17.2 35 1.50 0.26 17.6 
FeedMean 35 19.4 0.89 4.6 35 18.6 1.33 7.2 34 19.0 1.46 7.7 35 18.8 1.38 7.3 35 19.7 1.47 7.4 
Haematology Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
WBC 20 7.66 1.59 20.8 20 7.20 1.50 20.9 20 8.57 1.59 18.6 20 7.81 1.18 15.1 20 8.15 1.08 13.2 
RBC 20 8.48 0.27 3.2 20 8.50 0.35 4.1 20 8.45 0.38 4.5 20 8.65 0.35 4.0 20 8.58 0.44 5.2 
HGB 20 15.8 0.26 1.7 20 15.9 0.50 3.1 20 15.9 0.49 3.1 20 16.0 0.45 2.8 20 16.0 0.61 3.8 
HCT 20 46.1 1.29 2.8 20 46.3 1.53 3.3 20 46.5 2.07 4.5 20 47.2 1.35 2.9 20 46.8 2.15 4.6 
MCV 20 54.4 1.55 2.9 20 54.6 1.56 2.9 20 55.0 1.56 2.8 20 54.6 1.52 2.8 20 54.8 1.20 2.2 
MCH 20 18.7 0.63 3.4 20 18.8 0.73 3.9 20 18.8 0.74 3.9 20 18.5 0.76 4.1 20 18.7 0.65 3.5 
MCHC 20 34.3 0.57 1.7 20 34.3 0.76 2.2 20 34.2 0.90 2.6 20 33.9 0.64 1.9 20 34.2 0.72 2.1 
PLT 20 814 66.5 8.2 20 807 60.7 7.5 20 879 84.5 9.6 20 834 80.8 9.7 20 883 83.6 9.5 
LYMR 20 66.9 8.77 13.1 20 66.8 5.02 7.5 20 69.5 8.88 12.8 20 67.5 8.09 12.0 20 65.5 7.83 12.0 
LYMA 20 5.13 1.25 24.4 20 4.98 1.18 23.8 20 5.90 1.23 20.9 20 5.25 0.85 16.2 20 5.31 1.10 20.7 
ClinChem Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
ALP 20 1.23 0.22 17.7 20 1.33 0.26 19.5 20 1.26 0.21 16.3 20 1.31 0.21 16.1 20 1.26 0.22 17.7 
ALT 20 0.66 0.11 17.2 20 0.68 0.19 28.6 20 0.64 0.11 16.9 20 0.72 0.18 24.6 20 0.69 0.14 19.8 
AST 20 2.30 0.38 16.6 20 2.39 0.52 21.8 20 2.29 0.33 14.6 20 2.28 0.54 23.8 20 2.32 0.58 25.0 
BIL 20 7.10 1.62 22.8 20 6.82 1.02 15.0 20 6.94 1.03 14.8 20 6.71 1.15 17.1 20 7.20 1.14 15.8 
ALB 20 37.7 1.22 3.2 20 37.4 1.05 2.8 20 38.0 1.02 2.7 20 37.5 1.10 2.9 20 37.5 1.37 3.6 
TP 20 69.0 1.80 2.6 20 68.4 1.79 2.6 20 69.3 1.51 2.2 20 68.8 2.05 3.0 20 68.8 1.80 2.6 
Glu 20 5.35 0.59 11.1 20 5.43 0.82 15.1 20 5.26 0.47 8.9 20 5.69 1.16 20.4 20 5.40 0.60 11.2 
CHOL 20 2.74 0.35 12.8 20 2.82 0.38 13.6 20 2.85 0.50 17.4 20 2.64 0.45 17.1 20 2.88 0.65 22.6 
TAG 20 1.78 0.59 33.0 20 1.82 0.45 24.6 20 2.01 0.58 28.6 20 2.05 0.67 32.5 20 2.01 0.56 28.0 
Crea 20 43.7 4.80 11.0 20 42.1 3.30 7.8 20 43.1 2.49 5.8 20 42.1 3.35 7.9 20 42.3 3.66 8.6 
Urea 20 4.37 0.39 9.0 20 4.32 0.49 11.4 20 4.38 0.46 10.6 20 4.58 0.58 12.6 20 4.28 0.54 12.7 
cHGB 20 65.0 33.7 51.8 20 57.3 16.3 28.4 20 66.6 20.6 31.0 20 67.6 33.3 49.3 20 65.9 22.8 34.7 
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Ca 20 2.54 0.034 1.3 20 2.55 0.051 2.0 20 2.55 0.045 1.8 20 2.54 0.062 2.4 20 2.54 0.043 1.7 
Cl 20 104 1.31 1.3 20 103 1.54 1.5 20 102 1.33 1.3 20 103 1.80 1.8 20 103 1.65 1.6 
K 20 4.80 0.34 7.1 20 4.77 0.23 4.8 20 4.88 0.30 6.1 20 4.81 0.26 5.4 20 4.80 0.27 5.7 
Na 20 143 2.07 1.4 20 144 1.84 1.3 20 143 1.55 1.1 20 144 2.28 1.6 20 143 2.74 1.9 
P 20 1.77 0.17 9.5 20 1.67 0.19 11.2 20 1.81 0.28 15.2 20 1.71 0.17 9.8 20 1.69 0.16 9.3 
Urine Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
uVol 15 15.6 3.48 22.4 15 15.2 2.70 17.8 15 12.9 3.28 25.4 16 13.1 4.12 31.4 15 14.8 3.05 20.6 
uVolW 15 2.67 0.69 25.7 15 2.63 0.57 21.6 15 2.19 0.57 26.1 16 2.21 0.74 33.2 15 2.48 0.62 24.9 
uLeu 15 276 153 55.5 15 174 141 80.9 15 285 141 49.4 16 157 138 87.8 15 168 146 86.6 
uOsmoll 15 561 107 19.0 15 558 114 20.4 15 646 94 14.5 16 650 172 26.5 15 595 85 14.4 
uKeton 15 0.52 0.39 76.4 15 0.55 0.48 87.9 15 0.92 0.28 30.3 16 0.36 0.36 101.5 15 0.55 0.46 82.8 
upH 15 6.77 0.29 4.3 15 6.63 0.34 5.1 15 6.82 0.36 5.3 16 6.88 0.38 5.5 15 6.62 0.43 6.5 
Organs Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Kidney 10 0.45 0.042 9.5 10 0.47 0.037 7.7 10 0.48 0.082 17.1 10 0.45 0.050 11.1 10 0.45 0.044 9.8 
Spleen 10 0.17 0.018 10.6 10 0.17 0.013 7.7 10 0.18 0.017 9.6 10 0.17 0.031 18.6 10 0.17 0.017 10.1 
Liver 10 2.10 0.19 9.2 10 2.08 0.21 10.2 10 2.11 0.14 6.5 10 2.09 0.12 5.8 10 2.01 0.20 10.0 
AdrenGl 10 0.0088 0.0008 8.8 10 0.0094 0.0008 8.4 10 0.0095 0.0013 13.4 10 0.0083 0.0008 9.9 10 0.0091 0.0010 10.5 
Heart 10 0.20 0.011 5.4 10 0.21 0.020 9.2 10 0.22 0.024 10.9 10 0.20 0.008 4.1 10 0.20 0.012 6.2 
Testis 10 0.64 0.045 7.1 10 0.69 0.082 11.9 10 0.65 0.077 11.8 10 0.65 0.059 9.2 10 0.68 0.078 11.5 
Epididymis 10 0.22 0.024 11.1 10 0.24 0.028 11.5 10 0.22 0.030 13.3 10 0.21 0.027 13.1 10 0.23 0.030 13.2 
Brain 10 0.38 0.028 7.4 10 0.40 0.045 11.2 10 0.39 0.038 9.8 10 0.37 0.041 11.2 10 0.39 0.039 10.1 
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Table 8 Summary statistics for female rats classified by the feeding groups: number of cages (N), means (Mean), standard deviations (Sd) and 
coefficients of variation (CV). The summary statistics are obtained from cage means. 
Weights Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Weight_52 35 340 37.0 10.9 35 333 31.8 9.5 35 339 32.2 9.5 35 336 35.6 10.6 35 336 31.1 9.3 
growthRate 35 0.98 0.32 33.0 35 0.88 0.35 39.3 35 1.03 0.34 32.7 35 0.97 0.37 37.8 35 0.95 0.31 33.1 
FeedMean 35 14.2 0.94 6.6 35 13.9 1.17 8.4 34 14.3 0.95 6.7 35 13.9 1.02 7.3 35 14.4 0.92 6.4 
Haematology Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
WBC 20 5.57 1.34 24.0 20 5.94 1.53 25.8 20 5.13 0.96 18.7 20 5.45 1.19 21.8 20 5.88 1.28 21.8 
RBC 20 7.37 0.36 4.9 20 7.37 0.31 4.2 20 7.44 0.35 4.8 20 7.55 0.29 3.9 20 7.54 0.25 3.3 
HGB 20 15.4 0.53 3.4 20 15.4 0.52 3.4 20 15.5 0.51 3.3 20 15.6 0.48 3.1 20 15.5 0.54 3.5 
HCT 20 43.2 2.00 4.6 20 43.4 1.90 4.4 20 43.8 1.63 3.7 20 44.1 1.56 3.5 20 43.9 1.38 3.1 
MCV 20 58.7 0.86 1.5 20 58.9 1.16 2.0 20 58.7 1.25 2.1 20 58.4 0.98 1.7 20 58.2 1.19 2.0 
MCH 20 21.0 0.55 2.6 20 21.0 0.60 2.9 20 20.8 0.75 3.6 20 20.6 0.42 2.0 20 20.6 0.50 2.4 
MCHC 20 35.8 0.72 2.0 20 35.6 0.86 2.4 20 35.3 0.73 2.1 20 35.2 0.63 1.8 20 35.4 0.82 2.3 
PLT 20 755 75 10.0 20 792 103 13.0 20 751 74 9.9 20 764 79 10.3 20 784 97 12.4 
LYMR 20 69.9 7.41 10.6 19 70.0 5.44 7.8 20 71.4 7.50 10.5 20 70.0 6.10 8.7 20 70.6 3.68 5.2 
LYMA 20 3.86 0.97 25.0 20 3.92 0.63 16.1 20 3.57 0.60 16.9 20 3.78 0.67 17.7 20 4.04 0.80 19.8 
ClinChem Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
ALP 20 0.59 0.13 22.7 20 0.55 0.08 14.8 20 0.60 0.16 27.2 20 0.59 0.13 21.4 20 0.54 0.12 21.7 
ALT 20 0.74 0.18 24.2 20 0.70 0.18 26.0 20 0.71 0.15 21.3 20 0.65 0.27 40.9 20 0.72 0.13 17.7 
AST 20 2.59 0.62 23.8 20 2.52 0.49 19.6 20 2.69 0.50 18.8 20 2.55 0.81 31.7 20 2.73 0.73 26.6 
BIL 20 8.33 2.33 27.9 20 7.68 1.57 20.4 20 7.76 1.35 17.4 20 7.92 1.46 18.4 20 8.03 2.72 33.9 
ALB 20 42.4 1.91 4.5 20 42.5 2.12 5.0 20 43.0 2.14 5.0 20 43.3 3.00 6.9 20 42.4 2.16 5.1 
TP 20 71.9 2.11 2.9 20 71.8 2.30 3.2 20 72.1 2.23 3.1 20 71.9 2.63 3.7 20 71.7 2.72 3.8 
Glu 20 5.03 0.87 17.4 20 5.04 0.60 11.9 20 4.75 0.71 15.0 20 5.10 0.70 13.7 20 5.18 0.84 16.3 
CHOL 20 2.64 0.50 19.0 20 2.61 0.50 19.1 20 2.57 0.47 18.3 20 2.47 0.45 18.3 20 2.49 0.36 14.6 
TAG 20 0.96 0.22 22.7 20 0.90 0.23 25.8 20 1.01 0.31 30.2 20 1.21 1.08 89.1 20 0.98 0.25 25.2 
Crea 20 43.2 4.47 10.3 20 45.4 3.66 8.1 20 45.2 3.86 8.5 20 46.1 4.99 10.8 20 44.3 3.46 7.8 
Urea 20 4.63 0.44 9.5 20 4.99 0.48 9.5 20 5.17 0.57 10.9 20 5.05 0.68 13.5 20 4.98 0.54 10.9 
cHGB 20 54.0 35.1 65.1 20 43.1 13.5 31.3 20 47.3 18.1 38.3 20 50.8 29.2 57.5 20 52.4 37.8 72.2 
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Ca 20 2.57 0.042 1.7 20 2.58 0.049 1.9 20 2.58 0.054 2.1 20 2.59 0.058 2.2 20 2.56 0.032 1.2 
Cl 20 101 1.52 1.5 20 101 1.24 1.2 20 100 1.43 1.4 20 100 1.50 1.5 20 101 1.66 1.7 
K 20 4.36 0.28 6.5 20 4.38 0.40 9.1 20 4.36 0.29 6.7 20 4.37 0.39 8.9 20 4.42 0.52 11.7 
Na 20 141 1.92 1.4 20 142 2.28 1.6 20 142 1.80 1.3 20 142 2.17 1.5 20 142 2.30 1.6 
P 20 1.45 0.23 16.1 20 1.46 0.22 15.4 20 1.56 0.24 15.4 20 1.57 0.37 23.3 20 1.42 0.25 17.6 
Urine Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
uVol 15 13.6 2.52 18.5 16 14.0 5.66 40.4 16 13.1 3.71 28.4 15 14.1 4.89 34.7 15 12.7 3.36 26.4 
uVolW 15 4.00 0.72 17.9 16 4.28 1.63 38.1 16 3.91 1.26 32.1 15 4.27 1.83 43.0 15 3.87 1.01 26.1 
uLeu 15 66 88 133.0 16 84 92 110.4 16 134 148 110.2 15 79 100 126.3 15 73 96 131.4 
uOsmoll 15 491 77 15.7 16 498 120 24.1 16 534 185 34.7 15 482 109 22.7 15 531 115 21.7 
uKeton 15 0.15 0.21 138.0 16 0.27 0.38 143.6 16 0.28 0.33 116.5 15 0.05 0.10 207.0 15 0.20 0.24 117.6 
upH 15 6.53 0.28 4.3 16 6.44 0.40 6.3 16 6.42 0.35 5.5 15 6.70 0.33 4.9 15 6.42 0.29 4.6 
Organs Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Kidney 10 0.48 0.051 10.7 10 0.51 0.038 7.4 10 0.50 0.045 9.0 10 0.52 0.050 9.7 10 0.52 0.037 7.1 
Spleen 10 0.20 0.027 13.5 10 0.21 0.019 9.2 10 0.19 0.027 14.2 10 0.20 0.027 13.2 10 0.22 0.048 21.9 
Liver 10 2.01 0.19 9.5 10 2.05 0.18 8.8 10 2.02 0.15 7.3 10 2.06 0.11 5.3 10 2.06 0.15 7.3 
AdrenGl 10 0.019 0.0030 15.7 10 0.019 0.0016 8.3 10 0.019 0.0029 15.0 10 0.020 0.0034 17.4 10 0.020 0.0034 17.0 
Heart 10 0.25 0.022 8.8 10 0.26 0.018 6.7 10 0.27 0.032 11.9 10 0.26 0.017 6.7 10 0.26 0.016 5.9 
Uterus 10 0.26 0.062 23.9 10 0.28 0.071 25.8 10 0.24 0.056 23.7 10 0.25 0.052 20.4 10 0.25 0.048 19.1 
Ovary 10 0.018 0.0060 33.5 10 0.019 0.0033 17.4 10 0.021 0.0038 18.4 10 0.021 0.0066 31.5 10 0.021 0.0056 26.1 
Brain 10 0.59 0.061 10.2 10 0.65 0.069 10.6 10 0.64 0.067 10.5 10 0.64 0.060 9.3 10 0.65 0.038 5.8 
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3 Statistical analysis 
 
The statistical methods are described in the main study A report (Goedhart & van der Voet 2018). 
3.1 Equivalence testing using historical data 
Equivalence testing was only performed for those variables that were also observed in the GRACE 
study. Note that this is a comparison between data obtained after 12 months for the current study, 
and data obtained after 3 months for the historical GRACE study. It should be noted that the residual 
variances between cages may be much larger after 12 months than after 3 months (Figure 17). This in 
indicated by a yellow background colour of the endpoint labels in Figure 5 to Figure 8, and it shows 
that the model for equivalence testing which compares the current 12 months data to reference data 
obtained after 3 months data is not useful. The results reported in this section are only meant to 
illustrate this fact and are given for completeness only. 
The sample size in the current study, i.e. the number of cages per feeding group, equals 35 for the 
weight variables, 20 for haematology and clinical biochemistry, and 10 for relative organ weights. 
These sample sizes were used as the regulatory replication 𝑛𝑛0 in the equivalence analysis. Moreover 
regulatory values 𝛼𝛼 = 0.05 and 𝛽𝛽 = 0.05 were employed. Equivalence testing was only performed 
for those variables that were also observed in the GRACE study. Note that this is a comparison 
between data obtained after 12 months for the current study, and data obtained after 3 months for 
the historical GRACE study.  
Each GMO feed was tested for equivalence with respect to the control feed. The DWE intervals 
showing the main results of the equivalence tests for 34 variables are given in Figure 5 to Figure 8. 
The hypothesis of no difference is rejected in case the interval does not contain zero, which is 
denoted by fuchsia coloured estimates. The non-equivalence hypothesis is rejected when the interval 
fully lies inside the interval (-1,1). For further interpretation the 95% confidence intervals for the 
ratios are given in Table 9 and Table 10. These confidence intervals at the ratio scale are also given in 
Figure 9 to Figure 16, with inclusion of the estimated equivalence limits (red bars) and their 
uncertainty (blue bars). Note that the latter graphs cannot be used directly for performing the 
equivalence test. However, they show the effects and equivalence limits at a more familiar scale. 
Among 8×34 = 272 equivalence tests, there were 65 failures (24%) to prove equivalence (i.e. reject 
the hypothesis of non-equivalence). This high rate is mostly due to the fact that the residual 
variances after 12 months in the current study were often much larger than the residual variance 
after 3 months in the historical studies. The ratio of these residual variances (variance ratio or VR) 
was larger than 150% in 33 of the 68 cases (49%), in particular for the relative organ weights (Figure 
17). These endpoints with much more variation explain 63 of the 65 failures to prove equivalence, 
including 2 endpoints where the median estimate was outside the equivalence limits (Ovary, females 
NK33- and NK33+). For the other 63 cases of non-proven equivalence, the median estimate is within 
the equivalence limits, and thus, according to the terminology of EFSA (2011a), equivalence is still 
more likely than lack of equivalence. Only for 2 cases with a residual variance ratio smaller than 
150%, a failure to prove equivalence occurs (FeedMean, male NK11-, and Brain, female NK11-)  
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Although not the primary result of the equivalence analysis, it can also be observed from the fuchsia 
symbols in Figure 5 to Figure 8 and from Table 9 and Table 10 that, for those variables for which the 
equivalence test is performed, the number of significant differences, employing classical two-sided 
t-tests at the 5% level, equals 31 (11% of 272 difference tests, 13 for males and 18 for females). For 
the following cases both a significant difference and a failure to show equivalence occurred: 
FeedMean (NK11-) and Epididymus (NK11-) in males, and in females for MCHC (NK33-, NK11+), 
Kidney (NK11+, NK33+), Heart (NK33-) and Brain (NK11-, NK33+). 
For all difference tests, i.e. including those for which the equivalence test was not performed, 38 out 
of 352 t-tests were significant which is 11% of the tests.   
G-TwYST Study A  Statistical report month 12 
18 
 
 
Figure 5 Equivalence testing of NK11- and NK33- versus the control feed for males. For estimates 
(square symbols) on the left of zero the GM feed has a smaller mean than the control 
feed. See Table 9, Figure 9 and Figure 10 for further interpretation. Endpoints labelled 
with a golden background have a large residual variance compared to the historical 
studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 6 Equivalence testing of NK11+ and NK33+ versus the control feed for males. For estimates 
(square symbols) on the left of zero the GM feed has a smaller mean than the control 
feed. See Table 9, Figure 11 and Figure 12 for further interpretation. Endpoints labelled 
with a golden background have a large residual variance compared to the historical 
studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 7 Equivalence testing of NK11- and NK33- versus the control feed for females. For 
estimates (square symbols) on the left of zero the GM feed has a smaller mean than the 
control feed. See Table 10, Figure 13 and Figure 14 for further interpretation. Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 8 Equivalence testing of NK11+ and NK33+ versus the control feed for females. For 
estimates (square symbols) on the left of zero the GM feed has a smaller mean than the 
control feed. See Table 10, Figure 15 and Figure 16 for further interpretation. Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Table 9 95% Confidence interval plus estimate for the ratio Δ of the GMO feeds versus the Control feed for males. Intervals are based on an ANOVA 
with 5 feeding groups. Ratios with corresponding Intervals that do not encompass the value 1 are coloured red; this is equivalent to a 
significant difference according to a t-test with significance level 5%. 
Weights NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Weight_52 0.943 0.975 1.008 0.961 0.994 1.028 0.961 0.994 1.028 0.988 1.022 1.057 
growthRate 0.861 0.956 1.060 0.922 1.022 1.132 0.909 1.007 1.117 1.020 1.131 1.254 
FeedMean 0.931 0.958 0.985 0.948 0.975 1.003 0.941 0.968 0.996 0.986 1.014 1.043 
Haematology NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
WBC 0.840 0.941 1.054 0.997 1.116 1.250 0.910 1.021 1.146 0.960 1.075 1.204 
RBC 0.976 1.001 1.027 0.971 0.996 1.022 0.996 1.022 1.049 0.985 1.011 1.037 
HGB 0.989 1.005 1.022 0.988 1.005 1.021 0.996 1.013 1.030 0.992 1.008 1.025 
HCT 0.985 1.005 1.025 0.987 1.007 1.028 1.005 1.026 1.047 0.993 1.014 1.034 
MCV 0.986 1.004 1.021 0.994 1.011 1.029 0.986 1.004 1.022 0.990 1.007 1.025 
MCH 0.981 1.005 1.029 0.985 1.009 1.033 0.967 0.991 1.016 0.979 1.003 1.027 
MCHC 0.989 1.001 1.012 0.985 0.997 1.009 0.975 0.987 0.999 0.984 0.996 1.007 
PLT 0.933 0.989 1.048 1.015 1.076 1.141 0.969 1.028 1.090 1.021 1.082 1.147 
LYMR 0.938 1.003 1.073 0.972 1.040 1.112 0.953 1.020 1.092 0.918 0.981 1.049 
LYMA 0.850 0.965 1.095 1.021 1.159 1.316 0.916 1.042 1.185 0.911 1.034 1.174 
ClinChem NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
ALP 0.965 1.070 1.186 0.928 1.028 1.139 0.960 1.065 1.182 0.926 1.026 1.137 
ALT 0.915 1.012 1.119 0.883 0.977 1.080 0.950 1.052 1.166 0.937 1.036 1.146 
AST 0.922 1.020 1.128 0.899 0.994 1.100 0.847 0.939 1.040 0.892 0.987 1.092 
BIL 0.900 0.974 1.055 0.914 0.989 1.071 0.871 0.944 1.023 0.946 1.024 1.109 
ALB 0.974 0.992 1.011 0.991 1.009 1.027 0.979 0.997 1.016 0.977 0.995 1.013 
TP 0.977 0.991 1.006 0.991 1.005 1.020 0.983 0.997 1.011 0.983 0.997 1.012 
Glu 0.934 1.004 1.080 0.916 0.985 1.059 0.973 1.047 1.127 0.936 1.006 1.082 
CHOL 0.933 1.030 1.138 0.931 1.029 1.137 0.872 0.964 1.067 0.935 1.033 1.141 
TAG 0.880 1.027 1.199 0.963 1.124 1.312 1.009 1.181 1.382 0.976 1.139 1.329 
Crea 0.918 0.964 1.013 0.941 0.988 1.038 0.920 0.966 1.016 0.923 0.969 1.018 
Urea 0.930 0.987 1.047 0.942 0.999 1.060 0.984 1.045 1.110 0.919 0.975 1.034 
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cHGB 0.769 0.927 1.118 0.877 1.057 1.275 0.851 1.029 1.245 0.869 1.047 1.262 
Ca 0.990 1.000 1.010 0.993 1.003 1.012 0.990 1.000 1.010 0.987 0.997 1.006 
Cl 0.987 0.995 1.002 0.981 0.989 0.996 0.984 0.992 0.999 0.985 0.992 1.000 
K 0.964 0.996 1.029 0.983 1.015 1.049 0.972 1.005 1.039 0.969 1.001 1.034 
Na 0.993 1.000 1.008 0.991 0.998 1.006 0.993 1.000 1.008 0.992 1.000 1.007 
P 0.887 0.941 0.998 0.960 1.019 1.080 0.903 0.959 1.018 0.899 0.954 1.012 
Urine NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
uVol 0.860 1.003 1.170 0.716 0.835 0.974 0.734 0.856 0.998 0.823 0.960 1.120 
uVolW 0.860 1.007 1.181 0.710 0.832 0.975 0.712 0.834 0.977 0.801 0.939 1.100 
uLeu 0.350 0.606 1.051 0.585 1.014 1.757 0.345 0.598 1.036 0.337 0.585 1.013 
uOsmoll 0.882 1.012 1.161 1.031 1.182 1.357 0.998 1.145 1.314 0.942 1.081 1.240 
uKeton 0.715 1.029 1.480 1.168 1.680 2.417 0.552 0.794 1.142 0.748 1.076 1.548 
upH 0.666 0.875 1.151 0.800 1.051 1.382 0.841 1.105 1.453 0.655 0.861 1.132 
Organs NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Kidney 0.963 1.060 1.167 0.964 1.062 1.169 0.906 0.997 1.098 0.915 1.008 1.110 
Spleen 0.932 1.043 1.168 0.974 1.090 1.221 0.880 0.986 1.104 0.907 1.016 1.138 
Liver 0.927 0.996 1.070 0.941 1.011 1.086 0.932 1.001 1.076 0.890 0.957 1.028 
AdrenGl 0.984 1.067 1.157 0.987 1.070 1.161 0.867 0.940 1.019 0.949 1.028 1.115 
Heart 0.972 1.037 1.107 0.996 1.063 1.135 0.939 1.003 1.070 0.926 0.989 1.055 
Testis 0.990 1.075 1.167 0.938 1.019 1.106 0.934 1.013 1.100 0.969 1.052 1.142 
Epididymis 1.004 1.116 1.240 0.924 1.027 1.141 0.851 0.946 1.052 0.925 1.028 1.142 
Brain 0.990 1.057 1.128 0.951 1.016 1.084 0.905 0.967 1.032 0.946 1.010 1.078 
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Table 10 95% Confidence interval plus estimate for the ratio Δ of the GMO feeds versus the Control feed for females. Intervals are based on an ANOVA 
with 5 feeding groups. Ratios with corresponding Intervals that do not encompass the value 1 are coloured red; this is equivalent to a 
significant difference according to a t-test with significance level 5%. 
Weights NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Weight_52 0.944 0.980 1.018 0.960 0.997 1.036 0.950 0.986 1.024 0.952 0.989 1.027 
growthRate 0.776 0.903 1.051 0.904 1.052 1.224 0.848 0.986 1.148 0.828 0.963 1.121 
FeedMean 0.952 0.981 1.010 0.977 1.007 1.037 0.953 0.982 1.012 0.986 1.016 1.046 
Haematology NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
WBC 0.940 1.062 1.200 0.825 0.932 1.053 0.856 0.965 1.089 0.938 1.055 1.187 
RBC 0.976 1.003 1.030 0.986 1.013 1.041 0.999 1.026 1.053 0.998 1.024 1.051 
HGB 0.981 1.003 1.025 0.981 1.003 1.025 0.987 1.009 1.031 0.985 1.006 1.028 
HCT 0.985 1.009 1.034 0.992 1.016 1.041 0.996 1.020 1.045 0.991 1.015 1.039 
MCV 0.993 1.005 1.017 0.988 1.000 1.012 0.983 0.994 1.006 0.980 0.991 1.003 
MCH 0.983 1.000 1.018 0.973 0.990 1.008 0.965 0.982 0.999 0.966 0.982 0.999 
MCHC 0.981 0.994 1.007 0.974 0.987 1.000 0.973 0.985 0.998 0.979 0.991 1.004 
PLT 0.970 1.030 1.093 0.947 1.005 1.067 0.956 1.013 1.075 0.977 1.034 1.096 
LYMR 0.954 1.006 1.061 0.958 1.009 1.063 0.958 1.008 1.061 0.967 1.017 1.069 
LYMA 0.917 1.026 1.148 0.844 0.944 1.056 0.877 0.979 1.093 0.945 1.053 1.173 
ClinChem NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
ALP 0.869 0.983 1.113 0.901 1.020 1.154 0.898 1.014 1.145 0.834 0.940 1.059 
ALT 0.809 0.946 1.107 0.848 0.992 1.160 0.750 0.875 1.021 0.851 0.989 1.151 
AST 0.867 0.990 1.129 0.907 1.036 1.182 0.849 0.966 1.100 0.923 1.049 1.191 
BIL 0.840 0.924 1.017 0.874 0.962 1.058 0.879 0.965 1.060 0.870 0.954 1.046 
ALB 0.972 1.004 1.037 0.980 1.013 1.046 0.983 1.015 1.048 0.969 1.000 1.032 
TP 0.979 0.999 1.018 0.984 1.003 1.023 0.978 0.997 1.016 0.978 0.996 1.015 
Glu 0.938 1.010 1.087 0.897 0.965 1.039 0.965 1.037 1.115 0.962 1.032 1.108 
CHOL 0.889 0.987 1.096 0.854 0.949 1.054 0.831 0.921 1.021 0.863 0.955 1.056 
TAG 0.826 0.974 1.148 0.851 1.002 1.181 0.839 0.986 1.159 0.868 1.017 1.192 
Crea 0.998 1.052 1.110 0.984 1.038 1.095 1.006 1.060 1.118 0.978 1.029 1.084 
Urea 1.015 1.081 1.151 1.038 1.106 1.177 1.034 1.100 1.170 1.012 1.075 1.142 
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cHGB 0.731 0.884 1.068 0.811 0.981 1.185 0.800 0.964 1.161 0.807 0.969 1.162 
Ca 0.991 1.003 1.015 0.994 1.006 1.018 0.994 1.006 1.017 0.986 0.998 1.009 
Cl 0.999 1.008 1.017 0.991 1.000 1.009 0.990 0.998 1.007 0.991 0.999 1.008 
K 0.959 1.010 1.065 0.962 1.014 1.068 0.955 1.005 1.058 0.958 1.007 1.059 
Na 1.001 1.007 1.012 1.001 1.007 1.013 0.999 1.004 1.010 0.998 1.003 1.009 
P 0.906 1.011 1.129 0.965 1.078 1.204 0.944 1.053 1.173 0.880 0.979 1.089 
Urine NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
uVol 0.738 0.898 1.092 0.824 0.998 1.208 0.833 1.008 1.221 0.771 0.934 1.131 
uVolW 0.775 0.948 1.160 0.830 1.011 1.232 0.842 1.025 1.249 0.795 0.969 1.180 
uLeu 0.555 1.036 1.935 0.816 1.504 2.770 0.493 0.909 1.674 0.606 1.116 2.056 
uOsmoll 0.875 1.037 1.230 0.846 0.999 1.180 0.817 0.964 1.139 0.903 1.067 1.259 
uKeton 0.886 1.169 1.541 0.876 1.148 1.505 0.641 0.840 1.100 0.852 1.116 1.463 
upH 0.715 0.895 1.121 0.738 0.920 1.147 0.948 1.181 1.472 0.714 0.890 1.109 
Organs NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Kidney 0.996 1.071 1.152 0.974 1.048 1.127 1.006 1.081 1.163 1.007 1.083 1.165 
Spleen 0.965 1.087 1.224 0.874 0.984 1.108 0.925 1.042 1.173 0.981 1.105 1.245 
Liver 0.960 1.025 1.094 0.947 1.011 1.080 0.967 1.032 1.102 0.968 1.034 1.104 
AdrenGl 0.911 1.031 1.167 0.892 1.010 1.143 0.919 1.040 1.178 0.932 1.055 1.195 
Heart 0.995 1.063 1.136 1.014 1.083 1.157 0.977 1.043 1.115 0.997 1.065 1.138 
Uterus 0.851 1.053 1.304 0.726 0.899 1.113 0.808 1.000 1.239 0.797 0.987 1.223 
Ovary 0.867 1.110 1.420 0.940 1.202 1.539 0.922 1.180 1.509 0.963 1.233 1.577 
Brain 1.032 1.100 1.173 1.012 1.079 1.151 1.018 1.085 1.157 1.033 1.102 1.175 
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Figure 9 95% confidence intervals for the ratio of NK11- and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%).  
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Figure 10 95% confidence intervals for the ratio of NK33- and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 11 95% confidence intervals for the ratio of NK11+ and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 12 95% confidence intervals for the ratio of NK33+ and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 13 95% confidence intervals for the ratio of NK11- and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 14 95% confidence intervals for the ratio of NK33- and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 15 95% confidence intervals for the ratio of NK11+ and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 16 95% confidence intervals for the ratio of NK33+ and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). 
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Figure 17 Residual variance (sig2F or 𝝈𝝈𝑭𝑭𝟐𝟐) in the current G-TwYST A study as a percentage of the 
residual variance (sig2E or 𝝈𝝈𝑬𝑬𝟐𝟐) in the historical GRACE studies for males (top panel) and 
females (bottom panel). 
3.2 Equivalence testing using target effect sizes 
90% confidence intervals for 9 variables, with equivalence limits according to the targeted effect 
sizes in Hong et al. (2017), are given in Figure 18 for males and in Figure 19 for females. Note that 
these are 90% intervals, rather than the 95% intervals in Figure 9 to Figure 16. In all cases the null 
hypothesis of non-equivalence is rejected with most p-values smaller than 0.001 (Table 11).  
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Figure 18 90% confidence intervals for the ratio of the mean of the GMO feed and the control feed 
for selected variables for males along with equivalence intervals defined by targeted 
effect sizes of Hong et al. (2017). 
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Figure 19 90% confidence intervals for the ratio of the mean of the GMO feed and the control feed 
for selected variables for females along with equivalence intervals defined by targeted 
effect sizes of Hong et al. (2017). 
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Table 11 P-values of equivalence tests for the ratio of the mean of the GMO feed versus the mean 
of the control feed using targeted effect sizes of Hong et al. (2017) as equivalence limits. 
P-values smaller than 0.01/0.05 have a gold/yellow background. 
Variable 
Males Females 
NK11- NK33- NK11+ NK33+ NK11- NK33- NK11+ NK33+ 
Weight_52 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
WBC 0.000 0.005 0.000 0.001 0.001 0.000 0.000 0.000 
LYMA 0.000 0.038 0.001 0.000 0.000 0.000 0.000 0.000 
ALP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Crea 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Urea 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
CHOL 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Kidney 0.001 0.001 0.000 0.000 0.000 0.000 0.000 0.000 
Liver 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
3.3 Classical statistical analysis 
A classical analysis of variance was performed on the cage means after log transforming the data. 
Note that the ANOVA residuals were already assessed by means of a normal probability plot 
(Appendix 5) and a plot of residuals versus fitted values (Appendix 6). Table 12 (males) and Table 13 
(females) present the results of the t-tests, of Dunnett’s tests and of Wilcoxon tests for the 44 
variables divided in five groups. For ease of interpretation results are expressed as means and 
coefficients of variation on the original scale, rather than as means and standard deviations on the 
log scale. Note however that 95% confidence intervals on the ratio scale are given in Table 9 (males) 
and Table 10 (females).  
Results of the t-test and Dunnett’s test for the difference are summarized by letters which indicate 
significance at 5% and at 1%. Results for the non-parametric Wilcoxon test, where each test only uses 
data for the specific GM feed and the non-GM Control feed, are summarized in the same way. Exact 
p-values for these tests are given in Appendix 9. 
It can be seen (Table 12 and Table 13) that the relative precision of variables ranges from high to low 
precision. CVs smaller than 10% are observed for many variables, while CVs larger than 50% are 
observed for cHGB, uLeu and uKeton. For cHGB, growthRate, uLeu and uKeton there is a large 
difference in precision for males and females. 
In 46 cases (13% of the 352 comparisons) a difference was significant in at least one of the tests at 
the 5% level. On their own, Dunnett’s test resulted in 10 significant differences (2.8%), the t-test 
resulted in 38 significant differences (11%), and Wilcoxon’s test resulted in 32 significant differences 
(9%). Note that cells coloured red in Table 9 and Table 10, with 95% confidence intervals for ratios, 
correspond to cells coloured red in Table 12 and Table 13 with letters “t”, “T”, “d” or “D”. 
Results of the Shapiro-Wilks test for normality and Bartlett’s and Levene’s test for homogeneity of 
variance are given in Appendix 10. Bartlett’s’ test is significant at the 5% level for males for 3 
variables (FeedMean, HGB, Glu) and for females also for 3 variables (LYMR, TAG, uKeton). Levene’s 
test is significant for uOsmoll in males, and for 5 variables in females  (LYMR, TAG, uOsmoll, uKeton, 
Ovary). This implies that the important assumption of homogeneity of variance is generally fulfilled. 
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For these significant cases, one might resort to Wilcoxon’s test which is, for these cases, only 
significant for FeedMean in males (NK11-, NK33- and NK11+). 
The Shapiro-Wilks test for non-normality for separate feeding groups (Appendix 10) is frequently 
significant. However the normality assumptions is not very important. Moreover normal probability 
plots (Appendix 5) and plots of residuals versus fitted values (Appendix 6) were generally satisfactory. 
Also, graphs of cage means on the log scale in Appendix 4 indicate that significance of non-normality 
seems mostly due to one outlying observation in a feeding group. 
3.4 Standardized effect sizes 
SES intervals were calculated for all 44 variables. Results for the four treatment groups, separately 
for males and females, are given in Figure 20 to Figure 23. The number of intervals that extend 
outside the -/+ 1 SD limits equals 141 out of 352 (40%). 
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Table 12 Means and coefficient of variation (CV) for male rats. Means of GM feeds which are significantly different from the non-GM Control feed are 
marked, with red background colouring, as follows: D: P<0.01 by Dunnett-test, d: P<0.05 by Dunnett-test, T: P<0.01 by t-test but not by 
Dunnett-test, t: P<0.05 by t-test but not by Dunnett-test, W: P<0.01 by Wilcoxon signed rank test, w: P<0.05 by Wilcoxon signed rank test. 
Dunnett- and t-tests are based on an ANOVA with 5 treatment groups, while Wilcoxon tests only uses data for the specific GM feed and the 
control feed. 
Weights Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Weight_52 599.1 6.9 586.1 10.3  597.7 9.4  596.8 9.1  614.1 9.8  
growthRate 1.372 15.5 1.322 20.1  1.394 16.6  1.380 17.2  1.495 17.6 tw 
FeedMean 19.42 4.6 18.63 7.2 dTW 19.02 7.7 w 18.83 7.3 tW 19.73 7.4  
Haematology Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
WBC 7.657 20.8 7.197 20.9  8.570 18.6  7.807 15.1  8.155 13.2  
RBC 8.482 3.2 8.496 4.1  8.453 4.5  8.647 4.0  8.582 5.2  
HGB 15.82 1.7 15.91 3.1  15.90 3.1  15.99 2.8  15.96 3.8  
HCT 46.12 2.8 46.34 3.3  46.49 4.5  47.19 2.9 tw 46.77 4.6  
MCV 54.41 2.9 54.61 2.9  55.03 2.8  54.63 2.8  54.81 2.2  
MCH 18.68 3.4 18.77 3.9  18.85 3.9  18.53 4.1  18.74 3.5  
MCHC 34.33 1.7 34.35 2.2  34.23 2.6  33.89 1.9 tw 34.18 2.1  
PLT 813.8 8.2 807.0 7.5  878.7 9.6 d 834.4 9.7  882.5 9.5 dTW 
LYMR 66.92 13.1 66.78 7.5  69.53 12.8  67.55 12.0  65.49 12.0  
LYMA 5.127 24.4 4.978 23.8  5.900 20.9 t 5.255 16.2  5.315 20.7  
ClinChem Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
ALP 1.231 17.7 1.332 19.5  1.262 16.3  1.312 16.1  1.263 17.7  
ALT 0.659 17.2 0.679 28.6  0.643 16.9  0.720 24.6  0.690 19.8  
AST 2.304 16.6 2.386 21.8  2.291 14.6  2.281 23.8  2.319 25.0  
BIL 7.100 22.8 6.820 15.0  6.942 14.8  6.712 17.1  7.197 15.8  
ALB 37.66 3.2 37.38 2.8  37.99 2.7  37.46 2.9  37.46 3.6  
TP 68.99 2.6 68.40 2.6  69.34 2.2  68.77 3.0  68.81 2.6  
Glu 5.354 11.1 5.426 15.1  5.263 8.9  5.687 20.4  5.396 11.2  
CHOL 2.738 12.8 2.820 13.6  2.854 17.4  2.643 17.1  2.882 22.6  
TAG 1.781 33.0 1.821 24.6  2.011 28.6  2.048 32.5 tw 2.008 28.0  
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Crea 43.72 11.0 42.08 7.8  43.05 5.8  42.12 7.9  42.28 8.6  
Urea 4.372 9.0 4.323 11.4  4.376 10.6  4.579 12.6  4.282 12.7  
cHGB 65.01 51.8 57.30 28.4  66.60 31.0  67.57 49.3  65.92 34.7  
Ca 2.545 1.3 2.545 2.0  2.552 1.8  2.542 2.4  2.537 1.7  
Cl 103.6 1.3 103.0 1.5  102.4 1.3 dTW 102.6 1.8 tw 102.8 1.6 t 
K 4.805 7.1 4.775 4.8  4.880 6.1  4.815 5.4  4.803 5.7  
Na 143.5 1.4 143.5 1.3  143.2 1.1  143.6 1.6  143.4 1.9  
P 1.775 9.5 1.672 11.2 tW 1.812 15.2  1.713 9.8  1.693 9.3 w 
Urine Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
uVol 15.57 22.4 15.23 17.8  12.90 25.4 t 13.09 31.4 t 14.80 20.6  
uVolW 2.672 25.7 2.625 21.6  2.193 26.1 t 2.212 33.2 t 2.475 24.9  
uLeu 275.8 55.5 174.2 80.9  285.0 49.4  157.0 87.8 w 168.3 86.6  
uOsmoll 560.6 19.0 558.0 20.4  645.6 14.5 t 649.6 26.5  594.8 14.4  
uKeton 0.517 76.4 0.550 87.9  0.917 30.3 dTw 0.359 101.5  0.550 82.8  
upH 6.767 4.3 6.633 5.1  6.817 5.3  6.875 5.5  6.617 6.5  
Organs Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Kidney 0.447 9.5 0.472 7.7 w 0.477 17.1  0.446 11.1  0.449 9.8  
Spleen 0.166 10.6 0.173 7.7  0.181 9.6  0.166 18.6  0.169 10.1  
Liver 2.101 9.2 2.084 10.2  2.113 6.5  2.088 5.8  2.006 10.0  
AdrenGl 0.00883 8.8 0.00942 8.4 w 0.00948 13.4  0.00832 9.9  0.00913 10.5  
Heart 0.204 5.4 0.212 9.2  0.218 10.9  0.205 4.1  0.202 6.2  
Testis 0.640 7.1 0.691 11.9  0.653 11.8  0.649 9.2  0.676 11.5  
Epididymis 0.218 11.1 0.244 11.5 tw 0.224 13.3  0.207 13.1  0.225 13.2  
Brain 0.382 7.4 0.404 11.2  0.389 9.8  0.370 11.2  0.386 10.1  
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Table 13 Means and coefficient of variation (CV) for female rats. Means of GMO feeds which are significantly different from the Control feed are 
marked, with red background colouring, as follows: D: P<0.01 by Dunnett-test, d: P<0.05 by Dunnett-test, T: P<0.01 by t-test but not by 
Dunnett-test, t: P<0.05 by t-test but not by Dunnett-test, W: P<0.01 by Wilcoxon signed rank test, w: P<0.05 by Wilcoxon signed rank test. 
Note that Dunnett- and t-tests are based on a ANOVA with 5 treatment groups, while Wilcoxon tests only uses data for the specific GM feed 
and the control feed. 
Weights Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Weight_52 340.3 10.9 332.9 9.5  339.1 9.5  335.7 10.6  336.0 9.3  
growthRate 0.984 33.0 0.882 39.3  1.034 32.7  0.970 37.8  0.946 33.1  
FeedMean 14.18 6.6 13.93 8.4  14.29 6.7  13.94 7.3  14.41 6.4  
Haematology Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
WBC 5.565 24.0 5.935 25.8  5.130 18.7  5.447 21.8  5.877 21.8  
RBC 7.368 4.9 7.368 4.2  7.444 4.8  7.547 3.9 w 7.543 3.3  
HGB 15.45 3.4 15.44 3.4  15.46 3.3  15.57 3.1  15.54 3.5  
HCT 43.23 4.6 43.43 4.4  43.79 3.7 w 44.06 3.5  43.87 3.1  
MCV 58.70 1.5 58.94 2.0  58.71 2.1  58.41 1.7  58.19 2.0  
MCH 20.99 2.6 21.00 2.9  20.81 3.6  20.62 2.0 tW 20.61 2.4 t 
MCHC 35.76 2.0 35.58 2.4  35.32 2.1 tw 35.25 1.8 tw 35.45 2.3  
PLT 755.1 10.0 792.4 13.0  751.4 9.9  764.1 10.3  783.7 12.4  
LYMR 69.94 10.6 70.03 7.8  71.43 10.5  70.00 8.7  70.64 5.2  
LYMA 3.863 25.0 3.915 16.1  3.575 16.9  3.778 17.7  4.035 19.8  
ClinChem Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
ALP 0.586 22.7 0.549 14.8  0.602 27.2  0.593 21.4  0.542 21.7  
ALT 0.736 24.2 0.695 26.0  0.709 21.3  0.650 40.9  0.723 17.7  
AST 2.586 23.8 2.515 19.6  2.688 18.8  2.545 31.7  2.730 26.6  
BIL 8.332 27.9 7.678 20.4  7.758 17.4  7.922 18.4  8.027 33.9  
ALB 42.38 4.5 42.51 5.0  43.03 5.0  43.29 6.9  42.38 5.1  
TP 71.89 2.9 71.81 3.2  72.14 3.1  71.93 3.7  71.66 3.8  
Glu 5.028 17.4 5.043 11.9  4.745 15.0  5.103 13.7  5.175 16.3  
CHOL 2.638 19.0 2.607 19.1  2.574 18.3  2.474 18.3  2.487 14.6  
TAG 0.956 22.7 0.901 25.8  1.011 30.2  1.211 89.1  0.976 25.2  
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Crea 43.19 10.3 45.45 8.1  45.17 8.5  46.10 10.8 t 44.27 7.8  
Urea 4.634 9.5 4.986 9.5 tW 5.169 10.9 Dw 5.052 13.5 dTw 4.981 10.9 tw 
cHGB 54.00 65.1 43.06 31.3  47.27 38.3  50.78 57.5  52.42 72.2  
Ca 2.570 1.7 2.575 1.9  2.583 2.1  2.586 2.2  2.563 1.2  
Cl 100.6 1.5 101.3 1.2  100.5 1.4  100.2 1.5  100.5 1.7  
K 4.362 6.5 4.380 9.1  4.363 6.7  4.365 8.9  4.422 11.7  
Na 141.2 1.4 142.0 1.6 t 142.3 1.3 t 141.9 1.5  141.7 1.6  
P 1.450 16.1 1.456 15.4  1.562 15.4  1.573 23.3  1.424 17.6  
Urine Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
uVol 13.60 18.5 14.00 40.4  13.06 28.4  14.10 34.7  12.73 26.4  
uVolW 4.003 17.9 4.280 38.1  3.914 32.1  4.271 43.0  3.874 26.1  
uLeu 65.8 133.0 83.6 110.4  134.4 110.2  79.2 126.3  73.3 131.4  
uOsmoll 490.6 15.7 497.8 24.1  533.7 34.7  482.0 22.7  531.1 21.7  
uKeton 0.150 138.0 0.266 143.6  0.281 116.5  0.050 207.0  0.200 117.6  
upH 6.533 4.3 6.438 6.3  6.422 5.5  6.700 4.9  6.417 4.6  
Organs Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Kidney 0.480 10.7 0.512 7.4  0.502 9.0  0.517 9.7 tw 0.518 7.1 tw 
Spleen 0.197 13.5 0.211 9.2  0.192 14.2  0.203 13.2  0.220 21.9  
Liver 2.005 9.5 2.051 8.8  2.017 7.3  2.063 5.3  2.064 7.3  
AdrenGl 0.0189 15.7 0.0192 8.3  0.0190 15.0  0.0196 17.4  0.0199 17.0  
Heart 0.248 8.8 0.263 6.7 w 0.271 11.9 t 0.258 6.7  0.264 5.9  
Uterus 0.261 23.9 0.277 25.8  0.237 23.7  0.253 20.4  0.254 19.1  
Ovary 0.0179 33.5 0.0192 17.4  0.0207 18.4  0.0209 31.5  0.0214 26.1  
Brain 0.592 10.2 0.651 10.6 dTW 0.640 10.5 t 0.643 9.3 dw 0.651 5.8 dTW 
 
 
G-TwYST Study A  Statistical report month 12 
43 
 
 
Figure 20 Confidence intervals for Standardized Effect Sized (SES) for male rats for GMO feeds 
NK11- and NK33- versus the control feed. 
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Figure 21 Confidence intervals for Standardized Effect Sized (SES) for male rats for GMO feeds 
NK11+ and NK33+ versus the control feed. 
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Figure 22 Confidence intervals for Standardized Effect Sized (SES) for female rats for GMO feeds 
NK11- and NK33- versus the control feed. 
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Figure 23 Confidence intervals for Standardized Effect Sized (SES) for female rats for GMO feeds 
NK11+ and NK33+ versus the control feed. 
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3.5 Factorial analysis 
The significance results from fitting the factorial model to the 44 variables are given in Table 14. The 
ratios for the significant cases are shown in Table 15 and  
Table 16. As an example, consider the results for WBC which has a significant GM inclusion rate 
effect for males and a significant interaction for females. The effect of a higher GM inclusion rate is 
positive for males with a mean WBC value which is 12% higher at a GM inclusion rate of 33% as 
compared to a rate of 11% (Table 15). For females the effect of GM inclusion rate is negative for GM 
feeds without Roundup (1.00 to 0.88, i.e. -12%,  
Table 16), while the effect is positive for GM feeds with Roundup (0.91 to 0.99, i.e. +9%,  
Table 16). The only main significant GM inclusion rate effects larger than 10% were observed for 
WBC and uKeton in males. A significant Roundup main effects larger than 10% was observed for 
uKeton both in males and females. 
The p-values in Table 14 can be summarized as follows. In 8 out of 88 cases (9%) there was a 
significant difference at the 5% level between the mean of the GM feeds and the non-GM control 
feed. In 11 cases (12.5%) there was a significant interaction term at the 5% level. In these latter cases 
the main effects should not be used for assessing effects of GM inclusion rate or Roundup. Among 
the remaining 77 cases, i.e. where the interaction is not significant, there were 6 cases (7.8%) with a 
significant differences between GM inclusion rates, and 11 cases (14.3%) with a significant difference 
between the GM feeds with and without roundup.  
Table 14  P values for significance of effects obtained with the factorial model. P-values smaller 
than 0.01/0.05 have a gold/yellow background. 
Response Males Females 
Weights GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
Weight_52 0.771 0.055 0.051 0.723 0.432 0.474 0.922 0.588 
growthRate 0.520 0.015 0.038 0.510 0.674 0.238 0.995 0.107 
FeedMean 0.056 0.002 0.014 0.158 0.750 0.005 0.637 0.724 
Haematology GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
WBC 0.419 0.006 0.574 0.133 0.964 0.571 0.700 0.004 
RBC 0.454 0.390 0.052 0.748 0.080 0.613 0.043 0.480 
HGB 0.237 0.679 0.344 0.786 0.499 0.867 0.499 0.844 
HCT 0.106 0.517 0.059 0.298 0.075 0.890 0.510 0.416 
MCV 0.342 0.363 0.752 0.725 0.580 0.274 0.011 0.842 
MCH 0.846 0.346 0.244 0.656 0.057 0.371 0.014 0.329 
MCHC 0.273 0.546 0.069 0.140 0.020 0.860 0.632 0.114 
PLT 0.066 0.001 0.273 0.421 0.316 0.917 0.743 0.223 
LYMR 0.681 0.953 0.378 0.112 0.583 0.704 0.757 0.872 
LYMA 0.346 0.048 0.669 0.032 0.991 0.883 0.367 0.026 
ClinChem GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
ALP 0.252 0.277 0.928 0.977 0.790 0.602 0.502 0.140 
ALT 0.631 0.463 0.165 0.778 0.336 0.081 0.409 0.434 
AST 0.693 0.725 0.199 0.283 0.838 0.118 0.892 0.657 
BIL 0.569 0.081 0.954 0.234 0.130 0.631 0.548 0.385 
ALB 0.806 0.280 0.466 0.129 0.482 0.752 0.910 0.237 
TP 0.680 0.149 0.813 0.186 0.842 0.753 0.480 0.688 
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Glu 0.713 0.246 0.216 0.691 0.676 0.272 0.041 0.366 
CHOL 0.726 0.328 0.370 0.312 0.182 0.947 0.329 0.248 
TAG 0.071 0.613 0.159 0.243 0.926 0.552 0.782 0.983 
Crea 0.138 0.419 0.614 0.536 0.019 0.189 0.980 0.630 
Urea 0.964 0.170 0.426 0.051 0.000 0.991 0.772 0.240 
cHGB 0.850 0.254 0.470 0.383 0.416 0.352 0.520 0.394 
Ca 0.977 0.881 0.384 0.368 0.441 0.436 0.454 0.124 
Cl 0.006 0.339 0.929 0.196 0.626 0.199 0.051 0.081 
K 0.747 0.485 0.802 0.317 0.616 0.872 0.733 0.975 
Na 0.893 0.565 0.781 0.776 0.008 0.814 0.105 0.683 
P 0.154 0.075 0.255 0.041 0.444 0.890 0.406 0.047 
Urine GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
uVol 0.118 0.517 0.855 0.006 0.539 0.818 0.689 0.147 
uVolW 0.087 0.503 0.531 0.006 0.865 0.958 0.782 0.350 
uLeu 0.072 0.195 0.138 0.160 0.603 0.147 0.277 0.673 
uOsmoll 0.066 0.301 0.717 0.027 0.791 0.553 0.943 0.203 
uKeton 0.486 0.002 0.006 0.455 0.559 0.130 0.044 0.089 
upH 0.752 0.720 0.857 0.024 0.651 0.076 0.091 0.033 
Organs GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
Kidney 0.417 0.855 0.102 0.895 0.021 0.685 0.409 0.650 
Spleen 0.465 0.353 0.115 0.862 0.268 0.628 0.381 0.063 
Liver 0.747 0.550 0.325 0.228 0.331 0.792 0.526 0.750 
AdrenGl 0.437 0.107 0.005 0.130 0.491 0.940 0.548 0.686 
Heart 0.388 0.810 0.025 0.400 0.022 0.402 0.448 0.968 
Testis 0.235 0.772 0.641 0.121 0.841 0.256 0.776 0.335 
Epididymis 0.515 0.996 0.032 0.031 0.093 0.474 0.619 0.834 
Brain 0.649 0.933 0.044 0.074 0.001 0.926 0.873 0.452 
 
Table 15 Ratios for significant variables at the 5% level in the factorial analysis for males. Main 
effects are “GM vs Contrl” (ratio of the mean of the four GM feeds vs the control feed), 
“33 vs 11” (ratio of the two GM feeds with 33% GM inclusion rate vs the two feeds with 
11% GM inclusion rate) and “+RU vs -RU“ (ratio of the two GM feeds with roundup vs 
the two feeds without roundup). The interaction ratios are scaled such that NK11- 
equals 1. The InclRate and RndUp main effects are only given when the interaction is not 
significant. 
Males 
Group Variable 
GM vs 
Contrl 
33 vs 
11 
+RU vs 
-RU 
Interaction 
NK11- NK33- NK11+ NK33+ 
Weights growthRate - 1.10 1.08 - - - - 
Weights FeedMean - 1.03 1.03 - - - - 
Haematology WBC - 1.12 - - - - - 
Haematology PLT - 1.07 - - - - - 
Haematology LYMA - - - 1.00 1.20 1.08 1.07 
ClinChem Cl 0.99 - - - - - - 
ClinChem P - - - 1.00 1.08 1.02 1.01 
Urine uVol - - - 1.00 0.83 0.85 0.96 
Urine uVolW - - - 1.00 0.83 0.83 0.93 
Urine uOsmoll - - - 1.00 1.17 1.13 1.07 
Urine uKeton - 1.49 0.70 - - - - 
Urine upH - - - 1.00 1.20 1.26 0.98 
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Organs AdrenGl - - 0.92 - - - - 
Organs Heart - - 0.95 - - - - 
Organs Epididymis - - - 1.00 0.92 0.85 0.92 
Organs Brain - - 0.95 - - - - 
 
Table 16 Ratios for significant variables at the 5% level in the factorial analysis for females. Main 
effects are “GM vs Contrl” (ratio of the mean of the four GM feeds vs the control feed), 
“33 vs 11” (ratio of the two GM feeds with 33% GM inclusion rate vs the two feeds with 
11% GM inclusion rate) and “+RU vs -RU“ (ratio of the two GM feeds with roundup vs 
the two feeds without roundup). The interaction ratios are scaled such that NK11- 
equals 1. The InclRate and RndUp main effects are only given when the interaction is not 
significant. 
Females 
Group Variable 
GM vs 
Contrl 
33 vs 
11 
+RU vs 
-RU 
Interaction 
NK11- NK33- NK11+ NK33+ 
Weights FeedMean - 1.03 - - - - - 
Haematology WBC - - - 1.00 0.88 0.91 0.99 
Haematology RBC - - 1.02 - - - - 
Haematology MCV - - 0.99 - - - - 
Haematology MCH - - 0.99 - - - - 
Haematology MCHC 0.99 - - - - - - 
Haematology LYMA - - - 1.00 0.92 0.95 1.03 
ClinChem Glu - - 1.05 - - - - 
ClinChem Crea 1.04 - - - - - - 
ClinChem Urea 1.09 - - - - - - 
ClinChem Na 1.01 - - - - - - 
ClinChem P - - - 1.00 1.07 1.04 0.97 
Urine uKeton - - 0.84 - - - - 
Urine upH - - - 1.00 1.03 1.32 0.99 
Organs Kidney 1.07 - - - - - - 
Organs Heart 1.06 - - - - - - 
Organs Brain 1.09 - - - - - - 
 
3.6 Correlation analysis 
The correlation plots for three liver-related and three kidney-related variables in males and females 
are shown in Figure 24 - Figure 27. For males there were significant positive correlations between 
Urea and Crea for all comparisons (Figure 25), without accompanying correlations with the relative 
Kidney weights. Further significant (positive) correlations were found between ALP and CHOL in 
males, and between Kidney and Urea in females. Simultaneous exceedance of the threshold for two 
variables was only observed for Kidney and Urea for a single cage in females; the accompanying Crea 
value was close to the threshold for this cage. 
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Figure 24 Pairwise results for variables with set target effect sizes related to liver damage in 
Males. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
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Figure 25 Pairwise results for variables with set target effect sizes related to kidney damage in 
Males. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
  
G-TwYST Study A  Statistical report month 12 
52 
 
 
Figure 26 Pairwise results for variables with set target effect sizes related to liver damage in 
Females. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
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Figure 27 Pairwise results for variables with set target effect sizes related to kidney damage in 
Females. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
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Figure 24 Pairwise results for variables with set target effect sizes related to liver damage in Males. 
In each row there are four graphs corresponding to the four GM feed groups. Points 
represent the ratio of the cage mean for the GM group vs. the cage mean for the control 
feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the target effect 
sizes from Hong et al. (2017). 
Figure 25 Pairwise results for variables with set target effect sizes related to kidney damage in 
Males. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
Figure 26 Pairwise results for variables with set target effect sizes related to liver damage in 
Females. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
Figure 27 Pairwise results for variables with set target effect sizes related to kidney damage in 
Females. In each row there are four graphs corresponding to the four GM feed groups. 
Points represent the ratio of the cage mean for the GM group vs. the cage mean for the 
control feed in ten blocks. Horizontal and vertical lines represent a ratio of 1 and the 
target effect sizes from Hong et al. (2017). 
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Appendix 1. Growth curves per animal pair 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 2. Feed consumption per cage 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 3. Graphs of cage means on the original scale 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 5. Normal probability plots of residuals after ANOVA 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
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Appendix 7. Estimated differences between GMO feeds and the control feed 
The differences are given along with the residual sums of squares 𝑆𝑆𝑆𝑆𝐹𝐹 based on ANOVA on cage 
means after a log-transform. The degrees of freedom for the residual sums of squares equals 136 for 
Weight_13, growthRate and FeedMean, 76 for the other Male variables, and 75 for the other Female 
variables. Degrees of freedom are sometimes one less due to an occasional missing cage mean. 
Variable Male rats Female rats 
NK11- NK33- NK11+ NK33+ 𝑆𝑆𝑆𝑆𝐹𝐹  NK11- NK33- NK11+ NK33+ 𝑆𝑆𝑆𝑆𝐹𝐹  
Weight_52 -0.0254 -0.0063 -0.0059 0.0218 0.8692 -0.0198 -0.0027 -0.0138 -0.0114 0.8692 
FeedMean -0.0432 -0.0253 -0.0324 0.0140 0.5322 -0.0195 0.0069 -0.0182 0.0156 0.5322 
WBC -0.0607 0.1100 0.0209 0.0725 2.4769 0.0605 -0.0705 -0.0352 0.0533 2.4769 
RBC 0.0011 -0.0037 0.0216 0.0110 0.1197 0.0029 0.0129 0.0257 0.0240 0.1197 
HGB 0.0054 0.0045 0.0125 0.0084 0.0802 0.0028 0.0030 0.0086 0.0062 0.0802 
HCT 0.0047 0.0075 0.0255 0.0136 0.0992 0.0091 0.0162 0.0201 0.0150 0.0992 
MCV 0.0036 0.0113 0.0038 0.0072 0.0246 0.0050 0.0001 -0.0055 -0.0089 0.0246 
MCH 0.0046 0.0088 -0.0089 0.0027 0.0505 0.0002 -0.0098 -0.0185 -0.0181 0.0505 
MCHC 0.0005 -0.0031 -0.0130 -0.0045 0.0291 -0.0062 -0.0134 -0.0146 -0.0089 0.0291 
PLT -0.0113 0.0733 0.0274 0.0793 0.5907 0.0296 0.0055 0.0133 0.0338 0.5907 
LYMA -0.0359 0.1479 0.0412 0.0334 2.0886 0.0258 -0.0574 -0.0214 0.0516 2.0886 
ALP 0.0675 0.0276 0.0631 0.0253 2.5449 -0.0167 0.0196 0.0138 -0.0623 2.5449 
ALT 0.0121 -0.0235 0.0509 0.0353 4.0788 -0.0552 -0.0084 -0.1330 -0.0106 4.0788 
AST 0.0199 -0.0056 -0.0634 -0.0130 2.8953 -0.0105 0.0350 -0.0344 0.0474 2.8953 
BIL -0.0263 -0.0106 -0.0578 0.0241 1.5103 -0.0789 -0.0390 -0.0356 -0.0469 1.5103 
ALB -0.0077 0.0088 -0.0026 -0.0055 0.1771 0.0041 0.0128 0.0148 -0.0002 0.1771 
TP -0.0086 0.0052 -0.0031 -0.0026 0.0624 -0.0014 0.0029 -0.0032 -0.0037 0.0624 
Glu 0.0044 -0.0150 0.0460 0.0064 0.8968 0.0096 -0.0354 0.0362 0.0317 0.8968 
CHOL 0.0297 0.0285 -0.0362 0.0325 1.8216 -0.0127 -0.0525 -0.0818 -0.0464 1.8216 
TAG 0.0265 0.1168 0.1663 0.1300 4.4734 -0.0265 0.0023 -0.0139 0.0171 4.4734 
Crea -0.0362 -0.0120 -0.0342 -0.0310 0.4750 0.0510 0.0372 0.0585 0.0289 0.4750 
Urea -0.0133 -0.0011 0.0439 -0.0253 0.6561 0.0780 0.1003 0.0952 0.0721 0.6561 
cHGB -0.0754 0.0558 0.0289 0.0460 5.9418 -0.1237 -0.0197 -0.0369 -0.0319 5.9418 
Ca 0.0001 0.0026 0.0002 -0.0034 0.0225 0.0030 0.0058 0.0059 -0.0024 0.0225 
Cl -0.0054 -0.0112 -0.0085 -0.0076 0.0128 0.0083 0.0000 -0.0018 -0.0006 0.0128 
K -0.0042 0.0153 0.0045 0.0010 0.4542 0.0102 0.0135 0.0052 0.0073 0.4542 
Na 0.0004 -0.0019 0.0004 -0.0004 0.0054 0.0066 0.0069 0.0044 0.0033 0.0054 
P -0.0608 0.0184 -0.0419 -0.0473 2.0237 0.0113 0.0750 0.0513 -0.0215 2.0237 
Kidney 0.0582 0.0599 -0.0027 0.0079 0.2316 0.0687 0.0467 0.0783 0.0796 0.2316 
Spleen 0.0423 0.0864 -0.0144 0.0159 0.6181 0.0837 -0.0162 0.0408 0.1002 0.6181 
Liver -0.0044 0.0112 0.0013 -0.0444 0.1887 0.0246 0.0112 0.0319 0.0332 0.1887 
AdrenGl 0.0651 0.0681 -0.0622 0.0281 0.6723 0.0309 0.0100 0.0395 0.0539 0.6723 
Heart 0.0363 0.0611 0.0025 -0.0113 0.1926 0.0612 0.0799 0.0426 0.0631 0.1926 
Testis 
Uterus 
0.0722 0.0184 0.0133 0.0504 1.9999 
0.0520 -0.1070 0.0005 -0.0127 1.9999 
Epididymis 
Ovary 
0.1096 0.0266 -0.0553 0.0273 2.6593 
0.1040 0.1843 0.1652 0.2092 2.6593 
Brain 0.0555 0.0155 -0.0340 0.0099 0.1810 0.0953 0.0762 0.0819 0.0969 0.1810 
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Appendix 8. Intervals for equivalence tests 
95% Confidence interval plus estimate for the ratio Δ of a GMO feed versus the control feed, 95% Confidence 
interval plus median for (upper) equivalence limits, and the confidence interval plus median for Δ on the ELSD 
scale. Red background colouring indicates significant differences, green background colouring indicates 
significant equivalences (in all remaining cases equivalence is still more likely than not). 
Males  NK11- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
Weight_52 0.943 0.975 1.008 1.017 1.056 1.109 -2.000 -0.478 0.222 
FeedMean 0.931 0.958 0.985 1.037 1.080 1.161 -1.141 -0.554 -0.166 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
WBC 0.840 0.941 1.054 1.455 1.651 2.407 -0.321 -0.115 0.105 
RBC 0.976 1.001 1.027 1.083 1.109 1.144 -0.245 0.010 0.258 
HGB 0.989 1.005 1.022 1.079 1.100 1.146 -0.118 0.055 0.208 
HCT 0.985 1.005 1.025 1.089 1.112 1.148 -0.149 0.044 0.212 
MCV 0.986 1.004 1.021 1.005 1.024 1.039 -2.000 0.255 2.000 
MCH 0.981 1.005 1.029 1.010 1.036 1.060 -2.000 0.150 2.000 
MCHC 0.989 1.001 1.012 1.019 1.031 1.050 -0.406 0.017 0.428 
PLT 0.933 0.989 1.048 1.621 1.787 2.042 -0.108 -0.019 0.081 
LYMA 0.850 0.965 1.095 1.395 1.587 2.213 -0.323 -0.074 0.201 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
ALP 0.965 1.070 1.186 1.289 1.413 1.586 -0.103 0.194 0.466 
ALT 0.915 1.012 1.119 1.059 1.186 1.326 -1.266 0.075 2.000 
AST 0.922 1.020 1.128 1.216 1.337 1.528 -0.295 0.067 0.396 
ALB 0.974 0.992 1.011 1.102 1.127 1.161 -0.196 -0.065 0.088 
TP 0.977 0.991 1.006 1.075 1.093 1.120 -0.236 -0.096 0.064 
Glu 0.934 1.004 1.080 1.281 1.382 1.649 -0.217 0.012 0.231 
CHOL 0.933 1.030 1.138 1.087 1.230 1.576 -0.426 0.136 0.782 
TAG 0.880 1.027 1.199 1.736 2.120 4.335 -0.174 0.033 0.224 
Crea 0.918 0.964 1.013 1.282 1.362 1.567 -0.255 -0.114 0.041 
Urea 0.930 0.987 1.047 1.191 1.278 1.612 -0.274 -0.050 0.191 
Ca 0.990 1.000 1.010 1.131 1.161 1.237 -0.064 0.001 0.065 
Cl 0.987 0.995 1.002 1.102 1.124 1.171 -0.101 -0.045 0.018 
K 0.964 0.996 1.029 1.225 1.280 1.366 -0.139 -0.017 0.117 
Na 0.993 1.000 1.008 1.112 1.136 1.185 -0.056 0.003 0.060 
P 0.887 0.941 0.998 1.165 1.235 1.416 -0.555 -0.279 -0.009 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
Kidney 0.963 1.060 1.167 1.024 1.110 1.284 -2.000 0.907 2.000 
Spleen 0.932 1.043 1.168 1.070 1.184 1.329 -0.573 0.253 1.348 
Liver 0.927 0.996 1.070 1.032 1.101 1.189 -2.000 -0.048 2.000 
AdrenGl 0.984 1.067 1.157 1.279 1.371 1.568 -0.047 0.202 0.436 
Heart 0.972 1.037 1.107 1.059 1.121 1.223 -0.283 0.309 0.978 
Testis 0.990 1.075 1.167 1.112 1.185 1.274 -0.060 0.420 0.936 
Epididymis 1.004 1.116 1.240 1.058 1.162 1.375 0.033 0.754 2.000 
Brain 0.990 1.057 1.128 1.055 1.120 1.234 -0.095 0.481 1.276 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK33- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
Weight_52 0.961 0.994 1.028 1.017 1.063 1.109 -2.000 -0.121 2.000 
FeedMean 0.948 0.975 1.003 1.037 1.080 1.162 -0.798 -0.321 0.036 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
WBC 0.997 1.116 1.250 1.455 1.650 2.389 -0.007 0.211 0.433 
RBC 0.971 0.996 1.022 1.083 1.109 1.144 -0.267 -0.035 0.221 
HGB 0.988 1.005 1.021 1.079 1.100 1.146 -0.127 0.047 0.200 
HCT 0.987 1.007 1.028 1.089 1.112 1.148 -0.122 0.070 0.237 
MCV 0.994 1.011 1.029 1.005 1.024 1.047 -2.000 0.815 2.000 
MCH 0.985 1.009 1.033 1.010 1.037 1.060 -2.000 0.285 2.000 
MCHC 0.985 0.997 1.009 1.018 1.030 1.050 -0.482 -0.100 0.308 
PLT 1.015 1.076 1.141 1.622 1.786 2.041 0.026 0.126 0.216 
LYMA 1.021 1.159 1.316 1.396 1.587 2.217 0.043 0.310 0.591 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
ALP 0.928 1.028 1.139 1.289 1.413 1.585 -0.224 0.079 0.347 
ALT 0.883 0.977 1.080 1.060 1.186 1.326 -2.000 -0.145 0.876 
AST 0.899 0.994 1.100 1.217 1.337 1.529 -0.372 -0.019 0.349 
ALB 0.991 1.009 1.027 1.102 1.127 1.161 -0.080 0.073 0.204 
TP 0.991 1.005 1.020 1.075 1.093 1.120 -0.103 0.058 0.198 
Glu 0.916 0.985 1.059 1.282 1.381 1.647 -0.248 -0.045 0.180 
CHOL 0.931 1.029 1.137 1.087 1.230 1.576 -0.436 0.130 0.771 
TAG 0.963 1.124 1.312 1.735 2.122 4.306 -0.049 0.146 0.345 
Crea 0.941 0.988 1.038 1.282 1.362 1.564 -0.176 -0.038 0.120 
Urea 0.942 0.999 1.060 1.191 1.278 1.611 -0.251 -0.004 0.246 
Ca 0.993 1.003 1.012 1.131 1.161 1.237 -0.047 0.017 0.074 
Cl 0.981 0.989 0.996 1.102 1.124 1.172 -0.153 -0.094 -0.031 
K 0.983 1.015 1.049 1.225 1.280 1.366 -0.072 0.061 0.176 
Na 0.991 0.998 1.006 1.112 1.136 1.185 -0.066 -0.015 0.044 
P 0.960 1.019 1.080 1.165 1.235 1.415 -0.193 0.085 0.336 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
Kidney 0.964 1.062 1.169 1.024 1.110 1.288 -2.000 0.940 2.000 
Spleen 0.974 1.090 1.221 1.069 1.184 1.368 -0.191 0.519 1.827 
Liver 0.941 1.011 1.086 1.033 1.101 1.188 -2.000 0.122 2.000 
AdrenGl 0.987 1.070 1.161 1.279 1.370 1.565 -0.038 0.211 0.445 
Heart 0.996 1.063 1.135 1.059 1.122 1.221 -0.039 0.523 1.278 
Testis 0.938 1.019 1.106 1.112 1.185 1.273 -0.407 0.109 0.581 
Epididymis 0.924 1.027 1.141 1.058 1.161 1.269 -0.830 0.183 1.576 
Brain 0.951 1.016 1.084 1.055 1.119 1.235 -0.547 0.131 0.818 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK11+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
Weight_52 0.961 0.994 1.028 1.017 1.063 1.108 -2.000 -0.113 2.000 
FeedMean 0.941 0.968 0.996 1.038 1.080 1.162 -0.927 -0.410 -0.051 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
WBC 0.910 1.021 1.146 1.457 1.652 2.408 -0.186 0.039 0.246 
RBC 0.996 1.022 1.049 1.083 1.109 1.144 -0.040 0.207 0.436 
HGB 0.996 1.013 1.030 1.079 1.100 1.146 -0.044 0.127 0.287 
HCT 1.005 1.026 1.047 1.089 1.112 1.148 0.049 0.237 0.413 
MCV 0.986 1.004 1.022 1.005 1.024 1.040 -2.000 0.265 2.000 
MCH 0.967 0.991 1.016 1.010 1.037 1.060 -2.000 -0.288 2.000 
MCHC 0.975 0.987 0.999 1.018 1.031 1.050 -0.872 -0.424 -0.041 
PLT 0.969 1.028 1.090 1.621 1.787 2.042 -0.053 0.047 0.133 
LYMA 0.916 1.042 1.185 1.394 1.587 2.224 -0.187 0.085 0.334 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
ALP 0.960 1.065 1.182 1.289 1.412 1.584 -0.118 0.181 0.454 
ALT 0.950 1.052 1.166 1.060 1.186 1.327 -0.410 0.314 2.000 
AST 0.847 0.939 1.040 1.217 1.337 1.528 -0.549 -0.214 0.129 
ALB 0.979 0.997 1.016 1.103 1.127 1.161 -0.161 -0.021 0.133 
TP 0.983 0.997 1.011 1.075 1.093 1.120 -0.178 -0.035 0.126 
Glu 0.973 1.047 1.127 1.282 1.381 1.650 -0.081 0.138 0.339 
CHOL 0.872 0.964 1.067 1.088 1.227 1.574 -0.831 -0.168 0.380 
TAG 1.009 1.181 1.382 1.737 2.123 4.346 0.014 0.209 0.419 
Crea 0.920 0.966 1.016 1.282 1.362 1.569 -0.247 -0.107 0.048 
Urea 0.984 1.045 1.110 1.191 1.278 1.614 -0.060 0.169 0.405 
Ca 0.990 1.000 1.010 1.131 1.161 1.237 -0.064 0.002 0.065 
Cl 0.984 0.992 0.999 1.102 1.124 1.172 -0.128 -0.071 -0.009 
K 0.972 1.005 1.039 1.225 1.280 1.367 -0.116 0.018 0.139 
Na 0.993 1.000 1.008 1.112 1.136 1.186 -0.056 0.003 0.060 
P 0.903 0.959 1.018 1.164 1.235 1.415 -0.455 -0.193 0.078 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
Kidney 0.906 0.997 1.098 1.024 1.110 1.208 -2.000 -0.033 2.000 
Spleen 0.880 0.986 1.104 1.069 1.184 1.330 -1.159 -0.085 0.892 
Liver 0.932 1.001 1.076 1.032 1.101 1.190 -2.000 0.013 2.000 
AdrenGl 0.867 0.940 1.019 1.279 1.371 1.565 -0.423 -0.193 0.058 
Heart 0.939 1.003 1.070 1.059 1.122 1.224 -0.675 0.018 0.702 
Testis 0.934 1.013 1.100 1.112 1.185 1.273 -0.446 0.079 0.558 
Epididymis 0.851 0.946 1.052 1.058 1.162 1.259 -1.928 -0.381 0.451 
Brain 0.905 0.967 1.032 1.055 1.119 1.235 -0.995 -0.292 0.315 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK33+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
Weight_52 0.988 1.022 1.057 1.017 1.063 1.108 -0.341 0.414 2.000 
FeedMean 0.986 1.014 1.043 1.039 1.080 1.162 -0.202 0.176 0.589 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
WBC 0.960 1.075 1.204 1.458 1.651 2.377 -0.081 0.138 0.347 
RBC 0.985 1.011 1.037 1.083 1.109 1.144 -0.146 0.106 0.326 
HGB 0.992 1.008 1.025 1.079 1.100 1.146 -0.086 0.086 0.240 
HCT 0.993 1.014 1.034 1.089 1.112 1.148 -0.061 0.127 0.294 
MCV 0.990 1.007 1.025 1.005 1.024 1.043 -2.000 0.514 2.000 
MCH 0.979 1.003 1.027 1.010 1.037 1.060 -2.000 0.089 2.000 
MCHC 0.984 0.996 1.007 1.019 1.031 1.050 -0.526 -0.144 0.254 
PLT 1.021 1.082 1.147 1.622 1.786 2.042 0.035 0.136 0.226 
LYMA 0.911 1.034 1.174 1.397 1.588 2.221 -0.208 0.069 0.321 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
ALP 0.926 1.026 1.137 1.289 1.413 1.586 -0.231 0.072 0.342 
ALT 0.937 1.036 1.146 1.059 1.186 1.324 -0.653 0.216 2.000 
AST 0.892 0.987 1.092 1.217 1.337 1.530 -0.382 -0.044 0.325 
ALB 0.977 0.995 1.013 1.102 1.127 1.161 -0.178 -0.045 0.107 
TP 0.983 0.997 1.012 1.075 1.093 1.120 -0.173 -0.028 0.134 
Glu 0.936 1.006 1.082 1.281 1.382 1.648 -0.208 0.019 0.233 
CHOL 0.935 1.033 1.141 1.088 1.230 1.567 -0.407 0.149 0.805 
TAG 0.976 1.139 1.329 1.736 2.122 4.344 -0.030 0.162 0.365 
Crea 0.923 0.969 1.018 1.282 1.362 1.569 -0.237 -0.098 0.057 
Urea 0.919 0.975 1.034 1.191 1.278 1.617 -0.319 -0.097 0.139 
Ca 0.987 0.997 1.006 1.131 1.161 1.236 -0.078 -0.022 0.042 
Cl 0.985 0.992 1.000 1.102 1.124 1.172 -0.120 -0.064 -0.002 
K 0.969 1.001 1.034 1.225 1.280 1.367 -0.132 0.004 0.135 
Na 0.992 1.000 1.007 1.112 1.136 1.186 -0.060 -0.003 0.056 
P 0.899 0.954 1.012 1.165 1.235 1.419 -0.485 -0.217 0.055 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
Kidney 0.915 1.008 1.110 1.024 1.111 1.222 -2.000 0.119 2.000 
Spleen 0.907 1.016 1.138 1.070 1.184 1.331 -0.871 0.095 1.161 
Liver 0.890 0.957 1.028 1.033 1.101 1.190 -2.000 -0.486 0.397 
AdrenGl 0.949 1.028 1.115 1.279 1.371 1.568 -0.171 0.086 0.312 
Heart 0.926 0.989 1.055 1.059 1.122 1.222 -0.741 -0.095 0.563 
Testis 0.969 1.052 1.142 1.112 1.185 1.272 -0.198 0.293 0.774 
Epididymis 0.925 1.028 1.142 1.059 1.162 1.269 -0.834 0.185 1.591 
Brain 0.946 1.010 1.078 1.055 1.119 1.233 -0.611 0.083 0.767 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK11- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
Weight_52 0.944 0.980 1.018 1.027 1.078 1.142 -1.914 -0.266 0.321 
FeedMean 0.952 0.981 1.010 1.071 1.111 1.206 -0.457 -0.178 0.097 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
WBC 0.940 1.062 1.200 1.519 1.717 2.264 -0.105 0.108 0.303 
RBC 0.976 1.003 1.030 1.041 1.069 1.117 -0.384 0.041 0.441 
HGB 0.981 1.003 1.025 1.037 1.058 1.088 -0.349 0.048 0.417 
HCT 0.985 1.009 1.034 1.018 1.046 1.085 -0.418 0.204 1.024 
MCV 0.993 1.005 1.017 1.028 1.039 1.053 -0.180 0.129 0.406 
MCH 0.983 1.000 1.018 1.047 1.063 1.086 -0.278 0.004 0.283 
MCHC 0.981 0.994 1.007 1.010 1.024 1.037 -0.984 -0.261 0.327 
PLT 0.970 1.030 1.093 1.371 1.473 1.635 -0.072 0.076 0.205 
LYMA 0.917 1.026 1.148 1.511 1.694 2.196 -0.159 0.047 0.230 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
ALP 0.869 0.983 1.113 1.136 1.289 1.456 -0.590 -0.066 0.477 
ALT 0.809 0.946 1.107 1.446 1.657 1.977 -0.378 -0.108 0.199 
AST 0.867 0.990 1.129 1.302 1.464 1.704 -0.360 -0.026 0.324 
ALB 0.972 1.004 1.037 1.182 1.226 1.287 -0.136 0.020 0.162 
TP 0.979 0.999 1.018 1.160 1.201 1.325 -0.105 -0.007 0.096 
Glu 0.938 1.010 1.087 1.283 1.375 1.536 -0.196 0.030 0.234 
CHOL 0.889 0.987 1.096 1.098 1.226 1.405 -0.658 -0.063 0.547 
TAG 0.826 0.974 1.148 1.760 2.062 2.751 -0.236 -0.036 0.187 
Crea 0.998 1.052 1.110 1.265 1.354 1.678 -0.001 0.162 0.325 
Urea 1.015 1.081 1.151 1.227 1.325 1.733 0.053 0.264 0.493 
Ca 0.991 1.003 1.015 1.125 1.169 1.371 -0.052 0.018 0.082 
Cl 0.999 1.008 1.017 1.055 1.068 1.086 -0.004 0.125 0.240 
K 0.959 1.010 1.065 1.199 1.264 1.423 -0.173 0.042 0.238 
Na 1.001 1.007 1.012 1.055 1.067 1.093 0.016 0.100 0.179 
P 0.906 1.011 1.129 1.085 1.227 1.437 -0.671 0.055 0.808 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
Kidney 0.996 1.071 1.152 1.046 1.115 1.206 -0.045 0.643 1.901 
Spleen 0.965 1.087 1.224 1.120 1.236 1.355 -0.181 0.397 1.037 
Liver 0.960 1.025 1.094 1.143 1.202 1.314 -0.229 0.131 0.454 
AdrenGl 0.911 1.031 1.167 1.211 1.328 1.472 -0.350 0.108 0.517 
Heart 0.995 1.063 1.136 1.076 1.134 1.197 -0.042 0.481 1.081 
Uterus 0.851 1.053 1.304 1.188 1.427 1.700 -0.559 0.146 0.842 
Ovary 0.867 1.110 1.420 1.066 1.360 1.826 -2.000 0.567 2.000 
Brain 1.032 1.100 1.173 1.112 1.167 1.249 0.195 0.609 1.067 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK33- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
Weight_52 0.960 0.997 1.036 1.027 1.078 1.141 -1.399 -0.037 0.994 
FeedMean 0.977 1.007 1.037 1.071 1.111 1.205 -0.230 0.063 0.334 
    
Females NK33- lower esti upper lower median upper lower median upper 
WBC 0.825 0.932 1.053 1.519 1.716 2.261 -0.321 -0.126 0.088 
RBC 0.986 1.013 1.041 1.041 1.069 1.118 -0.207 0.188 0.576 
HGB 0.981 1.003 1.025 1.037 1.058 1.088 -0.345 0.050 0.419 
HCT 0.992 1.016 1.041 1.018 1.046 1.085 -0.191 0.363 1.293 
MCV 0.988 1.000 1.012 1.028 1.039 1.054 -0.317 0.004 0.320 
MCH 0.973 0.990 1.008 1.047 1.063 1.086 -0.407 -0.158 0.114 
MCHC 0.974 0.987 1.000 1.010 1.024 1.037 -1.471 -0.560 -0.026 
PLT 0.947 1.005 1.067 1.371 1.472 1.635 -0.137 0.013 0.153 
LYMA 0.844 0.944 1.056 1.511 1.694 2.189 -0.287 -0.107 0.096 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
ALP 0.901 1.020 1.154 1.136 1.289 1.456 -0.465 0.075 0.594 
ALT 0.848 0.992 1.160 1.446 1.658 1.978 -0.314 -0.016 0.294 
AST 0.907 1.036 1.182 1.300 1.463 1.708 -0.252 0.090 0.402 
ALB 0.980 1.013 1.046 1.182 1.226 1.286 -0.093 0.062 0.195 
TP 0.984 1.003 1.023 1.160 1.201 1.326 -0.087 0.015 0.107 
Glu 0.897 0.965 1.039 1.283 1.375 1.537 -0.305 -0.109 0.111 
CHOL 0.854 0.949 1.054 1.098 1.226 1.407 -0.876 -0.252 0.273 
TAG 0.851 1.002 1.181 1.760 2.062 2.759 -0.222 0.003 0.225 
Crea 0.984 1.038 1.095 1.265 1.354 1.680 -0.046 0.118 0.275 
Urea 1.038 1.106 1.177 1.227 1.325 1.727 0.115 0.343 0.588 
Ca 0.994 1.006 1.018 1.125 1.169 1.368 -0.034 0.034 0.100 
Cl 0.991 1.000 1.009 1.055 1.068 1.086 -0.131 0.000 0.131 
K 0.962 1.014 1.068 1.200 1.264 1.420 -0.157 0.056 0.247 
Na 1.001 1.007 1.013 1.055 1.067 1.093 0.021 0.105 0.182 
P 0.965 1.078 1.204 1.086 1.226 1.436 -0.178 0.369 1.243 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
Kidney 0.974 1.048 1.127 1.046 1.115 1.207 -0.288 0.438 1.547 
Spleen 0.874 0.984 1.108 1.120 1.236 1.350 -0.691 -0.077 0.562 
Liver 0.947 1.011 1.080 1.143 1.202 1.314 -0.308 0.059 0.394 
AdrenGl 0.892 1.010 1.143 1.211 1.328 1.471 -0.436 0.034 0.478 
Heart 1.014 1.083 1.157 1.076 1.135 1.197 0.106 0.629 1.261 
Uterus 0.726 0.899 1.113 1.186 1.425 1.700 -1.023 -0.300 0.342 
Ovary 0.940 1.202 1.539 1.066 1.359 1.970 -2.000 1.038 2.000 
Brain 1.012 1.079 1.151 1.113 1.167 1.249 0.072 0.485 0.919 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK11+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
Weight_52 0.950 0.986 1.024 1.026 1.078 1.141 -1.644 -0.184 0.470 
FeedMean 0.953 0.982 1.012 1.071 1.111 1.206 -0.444 -0.167 0.113 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
WBC 0.856 0.965 1.089 1.519 1.717 2.261 -0.257 -0.063 0.154 
RBC 0.999 1.026 1.053 1.041 1.069 1.118 -0.003 0.377 0.814 
HGB 0.987 1.009 1.031 1.037 1.058 1.088 -0.233 0.148 0.504 
HCT 0.996 1.020 1.045 1.018 1.046 1.085 -0.085 0.453 1.478 
MCV 0.983 0.994 1.006 1.028 1.039 1.054 -0.420 -0.142 0.167 
MCH 0.965 0.982 0.999 1.047 1.063 1.087 -0.561 -0.297 -0.025 
MCHC 0.973 0.985 0.998 1.010 1.024 1.037 -1.564 -0.610 -0.081 
PLT 0.956 1.013 1.075 1.371 1.473 1.637 -0.115 0.034 0.165 
LYMA 0.877 0.979 1.093 1.510 1.695 2.202 -0.225 -0.039 0.168 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
ALP 0.898 1.014 1.145 1.136 1.289 1.456 -0.494 0.053 0.586 
ALT 0.750 0.875 1.021 1.447 1.659 1.977 -0.544 -0.260 0.036 
AST 0.849 0.966 1.100 1.300 1.464 1.707 -0.399 -0.089 0.256 
ALB 0.983 1.015 1.048 1.181 1.226 1.287 -0.083 0.072 0.206 
TP 0.978 0.997 1.016 1.160 1.201 1.327 -0.108 -0.017 0.084 
Glu 0.965 1.037 1.115 1.283 1.375 1.536 -0.110 0.112 0.309 
CHOL 0.831 0.921 1.021 1.097 1.226 1.403 -1.077 -0.396 0.097 
TAG 0.839 0.986 1.159 1.759 2.063 2.757 -0.227 -0.018 0.204 
Crea 1.006 1.060 1.118 1.265 1.354 1.680 0.021 0.185 0.350 
Urea 1.034 1.100 1.170 1.227 1.325 1.731 0.100 0.325 0.564 
Ca 0.994 1.006 1.017 1.125 1.169 1.371 -0.034 0.035 0.101 
Cl 0.990 0.998 1.007 1.055 1.068 1.086 -0.142 -0.028 0.104 
K 0.955 1.005 1.058 1.199 1.264 1.421 -0.197 0.022 0.225 
Na 0.999 1.004 1.010 1.055 1.067 1.093 -0.016 0.067 0.142 
P 0.944 1.053 1.173 1.087 1.227 1.437 -0.332 0.251 1.040 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
Kidney 1.006 1.081 1.163 1.046 1.115 1.211 0.054 0.734 2.000 
Spleen 0.925 1.042 1.173 1.121 1.236 1.349 -0.420 0.193 0.789 
Liver 0.967 1.032 1.102 1.143 1.202 1.314 -0.191 0.170 0.494 
AdrenGl 0.919 1.040 1.178 1.211 1.328 1.473 -0.316 0.137 0.547 
Heart 0.977 1.043 1.115 1.075 1.134 1.195 -0.199 0.335 0.894 
Uterus 0.808 1.000 1.239 1.188 1.427 1.705 -0.770 0.001 0.777 
Ovary 0.922 1.180 1.509 1.066 1.359 1.928 -2.000 0.919 2.000 
Brain 1.018 1.085 1.157 1.112 1.167 1.247 0.110 0.522 0.966 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK33+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
Weight_52 0.952 0.989 1.027 1.026 1.078 1.142 -1.668 -0.154 0.564 
FeedMean 0.986 1.016 1.046 1.071 1.111 1.204 -0.136 0.144 0.417 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
WBC 0.938 1.055 1.187 1.519 1.717 2.261 -0.120 0.096 0.290 
RBC 0.998 1.024 1.051 1.041 1.069 1.118 -0.028 0.351 0.782 
HGB 0.985 1.006 1.028 1.037 1.058 1.088 -0.283 0.106 0.460 
HCT 0.991 1.015 1.039 1.017 1.046 1.084 -0.226 0.339 1.256 
MCV 0.980 0.991 1.003 1.028 1.039 1.054 -0.515 -0.228 0.077 
MCH 0.966 0.982 0.999 1.047 1.063 1.086 -0.552 -0.291 -0.022 
MCHC 0.979 0.991 1.004 1.010 1.024 1.037 -1.154 -0.372 0.178 
PLT 0.977 1.034 1.096 1.371 1.472 1.635 -0.061 0.087 0.216 
LYMA 0.945 1.053 1.173 1.510 1.695 2.195 -0.107 0.095 0.276 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
ALP 0.834 0.940 1.059 1.137 1.288 1.456 -0.781 -0.245 0.249 
ALT 0.851 0.989 1.151 1.447 1.657 1.975 -0.316 -0.021 0.290 
AST 0.923 1.049 1.191 1.301 1.464 1.707 -0.216 0.123 0.431 
ALB 0.969 1.000 1.032 1.182 1.226 1.287 -0.157 0.000 0.157 
TP 0.978 0.996 1.015 1.160 1.201 1.324 -0.111 -0.019 0.083 
Glu 0.962 1.032 1.108 1.283 1.375 1.536 -0.125 0.097 0.295 
CHOL 0.863 0.955 1.056 1.097 1.226 1.403 -0.832 -0.225 0.309 
TAG 0.868 1.017 1.192 1.762 2.063 2.740 -0.198 0.023 0.228 
Crea 0.978 1.029 1.084 1.265 1.353 1.679 -0.073 0.091 0.244 
Urea 1.012 1.075 1.142 1.228 1.325 1.730 0.036 0.243 0.468 
Ca 0.986 0.998 1.009 1.125 1.169 1.365 -0.079 -0.014 0.056 
Cl 0.991 0.999 1.008 1.055 1.068 1.086 -0.132 -0.008 0.122 
K 0.958 1.007 1.059 1.199 1.264 1.422 -0.187 0.030 0.228 
Na 0.998 1.003 1.009 1.055 1.067 1.093 -0.033 0.050 0.124 
P 0.880 0.979 1.089 1.086 1.224 1.435 -0.832 -0.106 0.565 
Organs Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
Kidney 1.007 1.083 1.165 1.046 1.115 1.209 0.066 0.747 2.000 
Spleen 0.981 1.105 1.245 1.120 1.235 1.356 -0.096 0.470 1.145 
Liver 0.968 1.034 1.104 1.144 1.202 1.313 -0.177 0.175 0.499 
AdrenGl 0.932 1.055 1.195 1.211 1.328 1.471 -0.264 0.188 0.595 
Heart 0.997 1.065 1.138 1.076 1.134 1.198 -0.024 0.498 1.102 
Uterus 0.797 0.987 1.223 1.187 1.427 1.704 -0.790 -0.036 0.721 
Ovary 0.963 1.233 1.577 1.066 1.361 2.009 -0.354 1.185 2.000 
Brain 1.033 1.102 1.175 1.112 1.167 1.248 0.204 0.618 1.081 
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Appendix 9. P-values for difference tests between GMO feeds and the control feed 
Difference tests are based on log transformed cage means. P-values are given for Dunnett tests (Dunnet), for t-tests and for Wilcoxon signed rank tests 
(Wilcox). P-values smaller than 0.01/0.05 have a gold/yellow background. 
Weights NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Weight_52 0.380 0.140 0.225 0.988 0.714 0.512 0.991 0.731 0.610 0.516 0.204 0.252 
growthRate 0.802 0.389 0.499 0.983 0.682 0.968 1.000 0.887 0.903 0.066 0.020 0.017 
FeedMean 0.010 0.003 0.003 0.236 0.080 0.021 0.081 0.025 0.008 0.723 0.327 0.280 
Haematology NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
WBC 0.668 0.290 0.294 0.175 0.057 0.202 0.989 0.719 0.465 0.522 0.207 0.475 
RBC 1.000 0.931 0.674 0.995 0.775 0.648 0.295 0.103 0.123 0.810 0.397 0.756 
HGB 0.919 0.524 0.571 0.953 0.589 0.433 0.396 0.147 0.112 0.705 0.315 0.457 
HCT 0.973 0.644 0.784 0.874 0.463 0.498 0.052 0.015 0.020 0.476 0.184 0.261 
MCV 0.983 0.683 0.648 0.513 0.202 0.143 0.981 0.673 0.798 0.827 0.413 0.123 
MCH 0.987 0.703 0.674 0.879 0.468 0.277 0.879 0.469 0.441 0.998 0.821 0.648 
MCHC 1.000 0.929 0.841 0.959 0.604 0.475 0.104 0.032 0.023 0.860 0.447 0.701 
PLT 0.986 0.700 0.898 0.048 0.014 0.064 0.765 0.359 0.145 0.029 0.008 0.006 
LYMR 1.000 0.928 0.898 0.601 0.250 0.349 0.940 0.562 0.515 0.947 0.575 0.701 
LYMA 0.947 0.574 0.312 0.075 0.023 0.083 0.920 0.526 0.395 0.958 0.601 1.000 
ClinChem NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
ALP 0.496 0.194 0.143 0.955 0.594 0.784 0.570 0.233 0.258 0.967 0.625 0.648 
ALT 0.998 0.811 0.898 0.973 0.644 0.475 0.719 0.325 0.332 0.893 0.487 0.622 
AST 0.985 0.696 0.498 1.000 0.913 0.898 0.549 0.222 0.293 0.997 0.797 0.898 
BIL 0.911 0.512 0.927 0.997 0.792 0.898 0.420 0.158 0.113 0.933 0.548 0.522 
ALB 0.816 0.402 0.268 0.735 0.337 0.261 0.996 0.781 1.000 0.935 0.552 0.452 
TP 0.572 0.234 0.368 0.881 0.471 0.729 0.979 0.667 0.651 0.989 0.720 0.522 
Glu 1.000 0.905 0.985 0.983 0.682 0.294 0.544 0.219 0.541 0.999 0.862 0.985 
CHOL 0.936 0.554 0.245 0.944 0.570 0.674 0.887 0.478 0.798 0.915 0.517 0.841 
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TAG 0.991 0.734 0.622 0.374 0.137 0.133 0.122 0.038 0.029 0.282 0.098 0.058 
Crea 0.389 0.144 0.261 0.968 0.627 0.648 0.455 0.174 0.145 0.526 0.209 0.475 
Urea 0.976 0.656 0.475 1.000 0.971 0.841 0.403 0.150 0.196 0.810 0.397 0.475 
cHGB 0.838 0.424 0.841 0.936 0.554 0.154 0.994 0.763 0.465 0.967 0.625 0.522 
Ca 1.000 0.985 0.898 0.954 0.590 0.452 1.000 0.965 0.922 0.898 0.493 0.622 
Cl 0.416 0.156 0.105 0.013 0.004 0.004 0.093 0.029 0.024 0.141 0.045 0.126 
K 0.997 0.801 1.000 0.762 0.357 0.430 0.996 0.788 0.925 1.000 0.954 0.952 
Na 1.000 0.923 0.481 0.965 0.620 0.816 1.000 0.924 0.794 1.000 0.913 0.365 
P 0.135 0.043 0.006 0.925 0.534 0.927 0.440 0.167 0.134 0.318 0.113 0.036 
Urine NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
uVol 1.000 0.966 1.000 0.073 0.022 0.079 0.147 0.048 0.078 0.957 0.599 0.890 
uVolW 1.000 0.926 0.934 0.077 0.024 0.107 0.083 0.026 0.055 0.840 0.427 0.599 
uLeu 0.218 0.074 0.064 1.000 0.960 0.937 0.198 0.066 0.012 0.169 0.055 0.166 
uOsmoll 0.999 0.862 0.599 0.059 0.018 0.064 0.163 0.053 0.151 0.615 0.260 0.421 
uKeton 1.000 0.877 0.783 0.021 0.006 0.018 0.522 0.208 0.227 0.983 0.688 0.494 
upH 0.729 0.333 0.319 0.988 0.716 0.842 0.876 0.467 0.557 0.644 0.277 0.259 
Organs NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Kidney 0.557 0.228 0.014 0.533 0.215 0.492 1.000 0.955 1.000 0.999 0.868 1.000 
Spleen 0.862 0.453 0.232 0.354 0.130 0.105 0.997 0.798 1.000 0.995 0.778 1.000 
Liver 1.000 0.902 0.922 0.993 0.754 0.770 1.000 0.971 0.770 0.536 0.217 0.131 
AdrenGl 0.310 0.111 0.027 0.274 0.096 0.160 0.349 0.128 0.193 0.889 0.486 0.625 
Heart 0.622 0.265 0.625 0.193 0.065 0.232 1.000 0.938 1.000 0.990 0.727 0.770 
Testis 0.239 0.082 0.064 0.974 0.652 0.770 0.992 0.744 1.000 0.542 0.220 0.160 
Epididymis 0.131 0.042 0.027 0.961 0.612 1.000 0.670 0.295 0.375 0.957 0.603 0.492 
Brain 0.268 0.094 0.160 0.969 0.634 0.922 0.676 0.299 0.322 0.994 0.762 0.432 
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Appendix 9. P-values for difference tests between GMO feeds and the control feed (continued) 
Difference tests are based on log transformed cage means. P-values are given for Dunnett tests (Dunnet), for t-tests and for Wilcoxon signed rank tests 
(Wilcox). P-values smaller than 0.01/0.05 have a gold/yellow background. 
Weights NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Weight_52 0.688 0.303 0.451 1.000 0.887 0.802 0.883 0.473 0.599 0.936 0.552 0.501 
growthRate 0.481 0.187 0.334 0.912 0.513 0.491 0.999 0.860 0.929 0.968 0.628 0.765 
FeedMean 0.503 0.197 0.245 0.975 0.651 0.601 0.562 0.228 0.265 0.683 0.300 0.184 
Haematology NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
WBC 0.726 0.327 0.671 0.611 0.253 0.054 0.941 0.561 0.441 0.781 0.369 0.349 
RBC 0.999 0.833 0.734 0.747 0.343 0.081 0.174 0.056 0.045 0.208 0.069 0.090 
HGB 0.997 0.801 0.899 0.997 0.790 0.442 0.844 0.428 0.374 0.943 0.564 0.784 
HCT 0.876 0.462 0.702 0.493 0.191 0.016 0.288 0.100 0.096 0.527 0.208 0.294 
MCV 0.831 0.415 0.347 1.000 0.985 0.899 0.771 0.361 0.332 0.377 0.137 0.070 
MCH 1.000 0.977 0.932 0.630 0.265 0.304 0.112 0.035 0.008 0.115 0.036 0.064 
MCHC 0.760 0.353 0.347 0.148 0.047 0.030 0.091 0.028 0.016 0.447 0.169 0.189 
PLT 0.725 0.326 0.369 0.999 0.856 0.702 0.976 0.653 0.768 0.595 0.245 0.701 
LYMR 0.999 0.831 0.854 0.991 0.733 0.734 0.994 0.756 0.984 0.913 0.511 0.546 
LYMA 0.975 0.648 0.899 0.703 0.311 0.167 0.986 0.700 0.568 0.750 0.345 0.452 
ClinChem NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
ALP 0.997 0.789 0.671 0.994 0.753 1.000 0.998 0.822 0.595 0.689 0.302 0.498 
ALT 0.894 0.485 0.393 1.000 0.915 0.495 0.262 0.090 0.156 1.000 0.889 0.409 
AST 1.000 0.874 0.899 0.958 0.599 0.442 0.958 0.599 0.651 0.874 0.460 0.498 
BIL 0.298 0.104 0.181 0.834 0.417 0.799 0.867 0.452 0.984 0.706 0.313 0.133 
ALB 0.997 0.804 0.523 0.855 0.438 0.246 0.771 0.362 0.332 1.000 0.990 0.784 
TP 1.000 0.888 0.966 0.995 0.767 0.640 0.992 0.737 0.953 0.985 0.695 0.571 
Glu 0.997 0.796 0.799 0.744 0.340 0.766 0.717 0.321 0.241 0.788 0.375 0.812 
CHOL 0.998 0.809 0.551 0.717 0.321 0.393 0.332 0.118 0.060 0.773 0.363 0.409 
G-TwYST Study A  Statistical report month 12 appendices 
166 
 
TAG 0.993 0.748 0.523 1.000 0.978 0.932 0.999 0.864 0.860 0.999 0.830 0.546 
Crea 0.187 0.061 0.130 0.449 0.170 0.393 0.096 0.030 0.123 0.634 0.267 0.409 
Urea 0.053 0.016 0.001 0.008 0.002 0.024 0.011 0.003 0.020 0.068 0.020 0.036 
cHGB 0.504 0.196 0.196 0.999 0.836 1.000 0.985 0.694 0.984 0.991 0.728 0.588 
Ca 0.960 0.604 0.442 0.722 0.324 0.468 0.698 0.308 0.352 0.980 0.668 0.277 
Cl 0.199 0.065 0.074 1.000 0.997 0.798 0.982 0.676 0.828 1.000 0.897 1.000 
K 0.986 0.698 0.865 0.962 0.609 0.570 0.999 0.839 0.922 0.995 0.773 0.898 
Na 0.079 0.024 0.099 0.062 0.019 0.058 0.336 0.120 0.163 0.576 0.234 0.268 
P 0.999 0.839 0.899 0.471 0.180 0.196 0.756 0.349 0.541 0.984 0.688 0.729 
Urine NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
uVol 0.640 0.273 0.286 1.000 0.982 0.820 1.000 0.933 0.851 0.885 0.476 0.679 
uVolW 0.957 0.600 0.808 1.000 0.912 0.934 0.997 0.801 0.890 0.993 0.750 0.639 
uLeu 1.000 0.910 0.918 0.480 0.186 0.344 0.993 0.754 0.918 0.989 0.720 0.844 
uOsmoll 0.979 0.666 0.542 1.000 0.992 0.934 0.978 0.662 0.934 0.853 0.440 0.454 
uKeton 0.623 0.263 0.348 0.698 0.311 0.438 0.509 0.201 0.120 0.833 0.419 0.399 
upH 0.722 0.327 0.433 0.864 0.452 0.365 0.369 0.135 0.204 0.671 0.293 0.233 
Organs NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Kidney 0.189 0.063 0.105 0.505 0.201 0.557 0.112 0.036 0.037 0.104 0.033 0.037 
Spleen 0.425 0.162 0.105 0.996 0.784 0.770 0.893 0.490 0.432 0.273 0.096 0.084 
Liver 0.861 0.452 0.557 0.991 0.732 0.846 0.723 0.331 0.375 0.696 0.312 0.322 
AdrenGl 0.962 0.616 0.770 0.999 0.870 0.846 0.915 0.522 0.625 0.791 0.384 0.193 
Heart 0.205 0.069 0.037 0.064 0.020 0.105 0.506 0.201 0.105 0.184 0.062 0.084 
Uterus 0.966 0.625 1.000 0.703 0.317 0.322 1.000 0.996 1.000 1.000 0.905 1.000 
Ovary 0.807 0.398 0.375 0.373 0.138 0.131 0.468 0.183 0.275 0.268 0.094 0.322 
Brain 0.017 0.005 0.010 0.070 0.022 0.064 0.047 0.014 0.049 0.015 0.004 0.004 
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Appendix 10. Tests for normality and homogeneity of variance 
P-values for the Shapiro-Wilks (SW) normality test are given separately for each feeding group, and also for the ANOVA residuals. In addition P-values for 
Bartlett and Levene test for homogeneity of variance are given. P-values smaller than 0.01/0.05 have a gold/yellow background. 
Male Weights SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Weight_52 0.294 0.742 0.642 0.766 0.771 0.150 0.232 0.189 
growthRate 0.589 0.338 0.572 0.684 0.496 0.158 0.670 0.713 
FeedMean 0.556 0.314 0.251 0.529 0.230 0.595 0.042 0.082 
Male Haematology SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
WBC 0.296 0.090 0.263 0.073 0.313 0.444 0.298 0.081 
RBC 0.281 0.774 0.605 0.705 0.680 0.174 0.392 0.445 
HGB 0.478 0.032 0.495 0.624 0.771 0.574 0.018 0.063 
HCT 0.879 0.356 0.893 0.956 0.368 0.985 0.077 0.238 
MCV 0.000 0.043 0.837 0.418 0.093 0.030 0.719 0.745 
MCH 0.000 0.070 0.406 0.581 0.637 0.019 0.832 0.473 
MCHC 0.409 0.334 0.470 0.129 0.908 0.620 0.345 0.644 
PLT 0.116 0.093 0.334 0.779 0.132 0.874 0.662 0.635 
LYMR 0.871 0.280 0.572 0.165 0.960 0.829 0.159 0.175 
LYMA 0.433 0.272 0.767 0.044 0.755 0.433 0.734 0.251 
Male ClinChem SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
ALP 0.739 0.441 0.632 0.093 0.978 0.794 0.988 0.999 
ALT 0.414 0.315 0.836 0.251 0.084 0.353 0.694 0.882 
AST 0.928 0.776 0.034 0.167 0.985 0.979 0.148 0.183 
BIL 0.078 0.957 0.145 0.004 0.701 0.205 0.780 0.948 
ALB 0.727 0.828 0.908 0.467 0.644 0.064 0.719 0.802 
TP 0.749 0.431 0.141 0.433 0.262 0.559 0.766 0.654 
Glu 0.477 0.432 0.990 0.228 0.642 0.185 0.024 0.131 
CHOL 0.084 0.101 0.916 0.790 0.700 0.168 0.227 0.248 
TAG 0.732 0.136 0.008 0.963 0.530 0.014 0.910 0.932 
Crea 0.764 0.048 0.890 0.507 0.535 0.843 0.133 0.088 
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Urea 0.059 0.930 0.758 0.947 0.033 0.300 0.500 0.819 
cHGB 0.080 0.708 0.379 0.669 0.790 0.108 0.546 0.806 
Ca 0.280 0.249 0.269 0.910 0.486 0.879 0.137 0.238 
Cl 0.394 0.459 0.268 0.523 0.636 0.425 0.606 0.737 
K 0.835 0.527 0.524 0.641 0.766 0.771 0.625 0.677 
Na 0.040 0.033 0.564 0.045 0.007 0.018 0.159 0.255 
P 0.617 0.413 0.001 0.709 0.645 0.162 0.484 0.803 
Male Urine SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
uVol 0.054 0.832 0.570 0.333 0.895 0.382 0.392 0.610 
uVolW 0.037 0.338 0.023 0.071 0.790 0.526 0.628 0.302 
uLeu 0.050 0.659 0.098 0.079 0.236 0.749 0.960 0.981 
uOsmoll 0.269 0.228 0.011 0.153 0.051 0.539 0.170 0.037 
uKeton 0.039 0.040 0.002 0.002 0.274 0.297 0.228 0.060 
upH 0.003 0.052 0.023 0.003 0.233 0.503 0.690 0.457 
Male Organs SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Kidney 0.738 0.163 0.333 0.083 0.211 0.201 0.199 0.214 
Spleen 0.743 0.921 0.017 0.678 0.432 0.493 0.064 0.325 
Liver 0.016 0.097 0.304 0.575 0.000 0.007 0.639 0.932 
AdrenGl 0.730 0.776 0.758 0.246 0.500 0.377 0.706 0.762 
Heart 0.074 0.484 0.175 0.595 0.056 0.182 0.056 0.112 
Testis 0.010 0.988 0.484 0.357 0.663 0.171 0.695 0.379 
Epididymis 0.034 0.784 0.018 0.439 0.329 0.706 0.970 0.760 
Brain 0.384 0.693 0.855 0.854 0.711 0.698 0.815 0.642 
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Appendix 10. Tests for normality and homogeneity of variance (continued) 
P-values for the Shapiro-Wilks (SW) normality test are given separately for each feeding group, and also for the ANOVA residuals. In addition P-values for 
Bartlett and Levene test for homogeneity of variance are given. P-values smaller than 0.01/0.05 have a gold/yellow background. 
Female Weights SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Weight_52 0.233 0.180 0.845 0.248 0.215 0.690 0.751 0.982 
growthRate 0.672 0.407 0.156 0.001 0.842 0.262 0.913 0.958 
FeedMean 0.131 0.743 0.665 0.246 0.392 0.397 0.507 0.837 
Female Haematology SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
WBC 0.898 0.052 0.067 0.848 0.135 0.388 0.850 0.929 
RBC 0.245 0.452 0.086 0.667 0.412 0.845 0.480 0.499 
HGB 0.083 0.219 0.194 0.040 0.579 0.057 0.981 0.916 
HCT 0.342 0.673 0.737 0.877 0.339 0.474 0.479 0.596 
MCV 0.256 0.054 0.560 0.159 0.236 0.271 0.480 0.722 
MCH 0.594 0.761 0.339 0.481 0.534 0.595 0.165 0.500 
MCHC 0.764 0.003 0.585 0.909 0.140 0.132 0.759 0.993 
PLT 0.190 0.012 0.639 0.133 0.460 0.301 0.785 0.563 
LYMR 0.288 0.667 0.702 0.270 0.353 0.003 0.012 0.028 
LYMA 0.994 0.102 0.493 0.817 0.142 0.775 0.240 0.253 
Female ClinChem SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
ALP 0.843 0.914 0.245 0.391 0.081 0.017 0.229 0.650 
ALT 0.284 0.293 0.461 0.061 0.202 0.605 0.231 0.492 
AST 0.562 0.245 0.234 0.172 0.263 0.035 0.366 0.289 
BIL 0.032 0.020 0.063 0.253 0.012 0.009 0.593 0.989 
ALB 0.737 0.012 0.748 0.517 0.069 0.562 0.384 0.223 
TP 0.179 0.052 0.972 0.806 0.007 0.106 0.836 0.979 
Glu 0.346 0.729 0.808 0.904 0.720 0.347 0.432 0.426 
CHOL 0.566 0.500 0.656 0.241 0.433 0.261 0.944 0.812 
TAG 0.458 0.496 0.775 0.003 0.037 0.118 0.000 0.001 
Crea 0.555 0.193 0.717 0.502 0.769 0.678 0.605 0.391 
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Urea 0.928 0.033 0.525 0.688 0.838 0.372 0.423 0.684 
cHGB 0.260 0.313 0.150 0.004 0.066 0.004 0.685 0.876 
Ca 0.779 0.788 0.166 0.497 0.999 0.252 0.112 0.188 
Cl 0.299 0.614 0.412 0.482 0.159 0.341 0.767 0.942 
K 0.043 0.910 0.331 0.292 0.658 0.721 0.131 0.137 
Na 0.267 0.182 0.001 0.040 0.751 0.476 0.786 0.739 
P 0.330 0.540 0.107 0.663 0.654 0.691 0.774 0.555 
Female Urine SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
uVol 0.132 0.311 0.485 0.283 0.991 0.330 0.127 0.245 
uVolW 0.022 0.488 0.607 0.165 0.194 0.433 0.102 0.295 
uLeu 0.016 0.139 0.220 0.317 0.003 0.149 0.535 0.235 
uOsmoll 0.122 0.127 0.997 0.057 0.558 0.642 0.071 0.044 
uKeton 0.001 0.001 0.010 0.000 0.003 0.664 0.014 0.002 
upH 0.276 0.141 0.278 0.129 0.126 0.905 0.668 0.771 
Female Organs SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Kidney 0.964 0.856 0.102 0.138 0.968 0.051 0.727 0.484 
Spleen 0.594 0.159 0.756 0.598 0.302 0.005 0.559 0.950 
Liver 0.515 0.988 0.518 0.220 0.291 0.810 0.587 0.679 
AdrenGl 0.321 0.811 0.812 0.802 0.685 0.233 0.268 0.286 
Heart 0.527 0.393 0.693 0.114 0.612 0.753 0.245 0.365 
Uterus 0.352 0.132 0.782 0.451 0.550 0.950 0.879 0.774 
Ovary 0.297 0.207 0.033 0.216 0.472 0.209 0.266 0.041 
Brain 0.088 0.428 0.614 0.509 0.540 0.747 0.434 0.574 
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Appendix 11. Statistical analysis of data including outliers 
For male animals there are outlying values for growthRate (1×), RBC (1×), HGB (1×), HCT (1×), Crea 
(1×) and Testis (1×), while for females there are outlying values for growthRate (2×), MCV (1×), LYMR 
(1×) and LYMA (1×); see Table 6 for a list of outliers. Equivalence tests, using the historical GRACE 
data, were not considered to be useful for the 12 months data and were therefore not repeated. 
Results  of the classical analysis without and with outliers are given in the tables below. Note that the 
top tables are identical to the values in Table 12 and Table 13.  
Conclusion: there are no essential differences between the analysis with and without outliers.  
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Without Outliers Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
growthRate 1.372 15.5 1.322 20.1  1.394 16.6  1.380 17.2  1.495 17.6 tw 
RBC 8.482 3.2 8.496 4.1  8.453 4.5  8.647 4.0  8.582 5.2  
HGB 15.82 1.7 15.91 3.1  15.90 3.1  15.99 2.8  15.96 3.8  
HCT 46.12 2.8 46.34 3.3  46.49 4.5  47.19 2.9 tw 46.77 4.6  
Crea 43.72 11.0 42.08 7.8  43.05 5.8  42.12 7.9  42.28 8.6  
Testis 0.640 7.1 0.691 11.9  0.653 11.8  0.649 9.2  0.676 11.5  
With Outliers Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
growthRate 1.372 15.5 1.292 24.3  1.394 16.6  1.380 17.2  1.495 17.6 tw 
RBC 8.482 3.2 8.496 4.1  8.453 4.5  8.647 4.0  8.475 6.0  
HGB 15.82 1.7 15.91 3.1  15.90 3.1  15.99 2.8  15.82 4.5  
HCT 46.12 2.8 46.34 3.3  46.49 4.5  47.19 2.9 tw 46.33 5.2  
Crea 43.72 11.0 42.08 7.8  43.05 5.8  42.77 12.6  42.28 8.6  
Testis 0.640 7.1 0.691 11.9  0.653 11.8  0.627 14.8  0.676 11.5  
 
Without Outliers Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
growthRate 0.984 33.0 0.882 39.3  1.034 32.7  0.970 37.8  0.946 33.1  
MCV 58.70 1.5 58.94 2.0  58.71 2.1  58.41 1.7  58.19 2.0  
LYMR 69.94 10.6 70.03 7.8  71.43 10.5  70.00 8.7  70.64 5.2  
LYMA 3.863 25.0 3.915 16.1  3.575 16.9  3.778 17.7  4.035 19.8  
With Outliers Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
growthRate 0.922 50.3 0.882 39.3  1.034 32.7  0.970 37.8  0.946 33.1  
MCV 58.70 1.5 58.94 2.0  58.90 2.9  58.41 1.7  58.19 2.0  
LYMR 69.94 10.6 68.58 12.2  71.43 10.5  70.00 8.7  70.64 5.2  
LYMA 3.840 26.4 3.915 16.1  3.575 16.9  3.778 17.7  4.035 19.8  
 
